The Effect of High-Intensity Interval Exercise on Postprandial Endothelial Function in Youth by Ryder, Justin R. (Author) et al.
The Effect of High-Intensity Interval Exercise on Postprandial Endothelial Function in 
Youth 
by 
 
Justin Ross Ryder 
 
 
 
 
 
A Dissertation Presented in Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy 
 
 
 
 
 
Approved April 2014 by the  
Graduate Supervisory Committee: 
 
Gabriel Shaibi, Chair 
Glenn Gaesser 
Sonia Vega-Lopez 
Noe Crespo 
Christos Katsanos 
 
 
 
 
ARIZONA STATE UNIVERSITY 
 
May 2014
i 
 
ABSTRACT  
In adults, consuming a high-fat meal can induce endothelial dysfunction while exercise 
may mitigate postprandial endothelial dysfunction. Whether exercise is protective against 
postprandial endothelial dysfunction in obese youth is unknown. The purpose of this 
study was to determine if high-intensity interval exercise (HIIE) performed the evening 
prior to a high-fat meal protects against postprandial endothelial dysfunction in obese 
adolescent males. Fourteen obese adolescent males (BMI%tile=98.5±0.6; 14.3±1.0yrs) 
completed the study. After initial screening, participants arrived, fasted at 9:00 in the 
morning where brachial artery flow-mediated dilation (FMD) was measured using duplex 
ultrasound after 20min of supine rest (7.0±3.0%) and completed a maximal exercise test 
on a cycle ergometer (VO2peak=2.6±0.5 L/min). Participants were randomized and 
completed 2 conditions: a morning high-fat meal challenge with evening prior HIIE 
(EX+M) or a morning high-fat meal challenge without prior exercise (MO). The EX+M 
condition included a single HIIE session on a cycle ergometer (8 X 2min at 
≥90%HRmax, with 2min active recovery between bouts, 42min total) which was 
performed at 17:00 the evening prior to the meal challenge. In both conditions, a mixed-
meal was tailored to participants body weight consisting of 0.7g of fat/kg of body weight 
consumed (889±95kcal; 65% Fat, 30% CHO). FMD was measured at fasting (>10hrs) 
and subsequently measured at 2hr and 4hr after high-fat meal consumption. Exercise did 
not improve fasting FMD (7.5±3.0 vs. 7.4±2.8%, P=0.927; EX+M and MO, 
respectively). Despite consuming a high-fat meal, FMD was not reduced at 2hr (8.4±3.4 
vs. 7.6±3.9%; EX+M and MO, respectively) or 4hr (8.8±3.9 vs. 8.6±4.0%; EX+M and 
MO, respectively) in either condition and no differences were observed between 
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condition (p(condition*time)=0.928).  These observations remained after adjusting for baseline 
artery diameter and shear rate. We observed that HIIE, the evening prior, had no effect on 
fasting or postprandial endothelial function when compared with a meal only condition. 
Future research should examine whether exercise training may be able to improve 
postprandial endothelial function rather than a single acute bout in obese youth.  
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CHAPTER 1: GENERAL INTRODUCTION 
Pediatric obesity represents one of the most significant public health challenges 
facing our society. Obese youth, particularly those at the higher end of the BMI spectrum 
(i.e. those above the 97
th
 percentile) are at increased risk for developing cardiovascular 
disease (CVD) and type 2 diabetes (T2D) (Bacha F, 2006; Srinivasan SR, 2006). Up to 
30% of obese youth > 97
th
 percentile exhibit the metabolic syndrome which tracks into 
adulthood and predicts the development of CVD and T2D (Cook, Weitzman, Auinger, 
Nguyen, & Dietz, 2003; Morrison, Friedman, & Gray-McGuire, 2007; Rodriguez et al., 
2006). This is further exacerbated by the fact that adolescents > 97
th
 percentile are the 
only growing population of obese youth (Ogden, Carroll, Kit, & Flegal, 2012), making 
this population of youth an optimal target for intervention. In addition to obesity, declines 
in physical activity levels are thought to contribute independently to increased chronic 
disease risk (Trigona et al., 2010; Trost et al., 2002).  The Exercise is Medicine
TM
 
campaign, supported by the American College of Sports Medicine (ACSM), necessitates 
that more effective exercise prescriptions are necessary to improve the health and reduce 
long-term disease risk among obese youth. Moreover, exercise prescriptions for obese 
youth should lead to clinically measurable improvements in health indicators.  
 A major challenge to addressing cardiovascular health in youth is the long latent 
period between elevated cardiovascular risk and future cardiovascular outcomes. 
Although the atherosclerotic process begins in childhood, it generally  remains 
subclinical for a number of years (Newman, Wattigney, & Berenson, 1991). Impaired 
endothelial function (i.e. endothelial dysfunction) is one of the earliest manifestations of 
atherosclerosis, (Jean Davignon & Peter Ganz, 2004) and non-invasive imaging 
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techniques provide an avenue to assess this subclinical process in younger populations 
(Urbina et al., 2009). Several studies suggest that obesity is associated with endothelial 
dysfunction in youth, but very few studies have evaluated whether endothelial 
dysfunction can be reversed via exercise in this population (Aggoun et al., 2008; 
Mahmud, Hill, Cuerden, & Clarson, 2009; Woo et al., 2004). The few studies to date 
which have utilized exercise as medicine for endothelial dysfunction have focused 
exclusively on endothelial function under fasting conditions (Kelly et al., 2004; Watts, 
Beye, Siafarikas, O'Driscoll, et al., 2004). Most recommendations for assessment of 
cardiovascular risk factors, including endothelial function, call for testing to occur after a 
prolonged fast; (Kavey et al., 2006; Thijssen et al., 2011) However, this state may not 
reflect the true physiologic nature of the vascular system in relation to health and disease 
(F. Kaufman, 2005). Humans spend most of their waking time in the postprandial state, 
and postprandial dysregulation of carbohydrate and fat are critical pathophysiologic 
processes underlying CVD and T2D (Ebenbichler, Kirchmair, Egger, & Patsch, 1995; 
Tushuizen, Diamant, & Heine, 2005). Moreover, it is clear that regular physical activity 
is cardioprotective, but the greatest benefit of exercise on cardiometabolic health may be 
observed during the postprandial state due to endothelial adaptation (Graham, 2004; 
Haram et al., 2006).  
 Evidence in adults suggests that exercise attenuates postprandial lipemia 
(Katsanos, 2006) and improves endothelial function (Gill et al, 2004). However, the 
majority of these studies use continuous exercise at a moderate intensity (i.e. traditional 
exercise) as the exercise prescription. Recent evidence suggests that high-intensity 
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exercise is more beneficial in improving markers of CVD among adults, including 
endothelial function, than a traditional clinical approach (Gibala, Little, Macdonald, & 
Hawley, 2012). These data are accompanied by evidence that high-intensity exercise 
completely ameliorates high-fat meal induced postprandial endothelial dysfunction 
(Tyldum et al., 2009). Nevertheless, despite the increasing literature to support intensity-
dependent benefits of exercise on cardiovascular outcomes,(Tanasescu et al., 2002) very 
few studies incorporate high-intensity exercise in youth (Ingul, Tjonna, Stolen, Stoylen, 
& Wisloff, 2010). In order to respond to the growing epidemic of obesity in youth, 
translational research on the effects of exercise on cardiovascular health is needed. 
Compiling this evidence using defined protocols and proximal indicators of vascular 
health is an essential step towards developing exercise prescriptions for disease 
prevention approaches. Therefore, the overall goal of this dissertation is to examine the 
potential for high-intensity exercise to improve postprandial endothelial function in obese 
youth.  
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CHAPTER 2: REVIEW OF LITERATURE 
Origins of Cardiovascular Disease 
 Seminal data using autopsy studies provided conclusive evidence that the earliest 
visual manifestations of the cardiovascular disease (CVD) process begin to appear at an 
early age. Strong and McGill dissected and removed 548 coronary arteries  via necropsy 
in persons aged 1-69.(J. Strong & McGill, 1962) The coronary arteries were then blindly 
evaluated for lesion presence (fatty streaks) and progression as well as fibrous plaque 
formation through visual and manual inspection. They observed that by age 10-19, 22 out 
of 44 (50%) individuals showed some lesion formation with the extent of lesion 
formation increasing with age. Additionally, they observed that while few persons age 
10-19 exhibited fibrous plaque formation (2 out of 44), this formation progressed with 
age in which 46 out of 86 (54%) showed plaque formation by age 30-39. Additionally, 
the cause of death from myocardial infarction increased with age and was associated with 
lesion and plaque development. Importantly, these early works provided evidence that 
while some youth show the presence of CVD morphology these formations do not lead to 
overt CVD outcomes until later in-life.  
 Follow up investigations by Strong and McGill showed earlier development of 
fatty streak lesion development. They examined autopsies of over 1600 persons and 
found that aortic fatty streaks are often present in children under age 3 and consistently 
present once children reach age 3.(J. Strong & McGill, 1963) While they did not observe 
coronary fatty streaks until age 10, the presence of fatty streaks was almost always 
observed by age 20. These observations were independent of race, ethnicity or 
geographic origin.(J. P. Strong & McGill Jr, 1969) This suggests that early 
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atherosclerotic development, particularly in the aorta, can be observed in just a few short 
years after birth, and its progression to other vessels is observed in a linear manner later 
in life.  
These studies laid the foundation for later studies to show that fatty streaks can 
develop in utero, wherein the fetuses of mothers with normal cholesterol levels show 
signs of fatty streak formation in 63.3% of aortic structures and up to 80% in mothers 
with hypercholesterolemia.(Napoli et al., 1997) These data are also supported by 
associative evidence that the fetal environment may be a key mediator in the 
development of atherosclerosis.(Barker, 1995) Therefore, since CVD has its antecedents 
early in life and is likely to be modulated by a number of early life factors. Therefore, 
early life is the most applicable population in which to investigate CVD and develop 
strategies to reduce disease risk. Particularly, between the ages of 10-20 years old where 
there is a progression from aortic lesion presence to more distal coronary artery lesion 
development, suggesting that this period may offer a unique window to reduce CVD 
development.  
The Endothelium  
 In a landmark paper published in 1980, Furchgott and Zawadski first described 
the obligatory role that the endothelial cells play in vasorelaxation (Furchgott & 
Zawadzki, 1980). They observed that the endothelium is required in order for 
acetylcholine to induce the release of a substance(s) that produces relaxation of the 
vascular smooth muscle. This suggests that vasorelaxation was dependent upon 
production of these substances from the endothelium, and without the endothelium, 
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acetylcholine could not cause the smooth muscle to relax. This breakthrough finding 
awarded Furchgott the Nobel Prize in 1998 and set the stage for the hunt for the elusive 
substance that the endothelium was producing, in response to acetylcholine, which 
resulted in vascular smooth muscle relaxation.  
 In subsequent studies, Furchgott’s group identified a number of substances (i.e. 
substance P, bradykinin, adenosine diphosphate, etc.) that produced endothelium-
dependent vasorelaxation in isolated arteries. However, it was unknown which of these 
substances was primarily responsible for vasodilation in vivo; thus, the elusive substance 
was termed endothelium-derived relaxing factor (EDRF)(Cherry, Furchgott, Zawadzki, & 
Jothianandan, 1982). It was evident that EDRF, whatever it was, likely stimulated 
guanylyl cyclase in vascular smooth muscle, which would result in an increased 
production of cyclic monophosphate (cGMP), and induce relaxation of the smooth 
muscle (Rapoport & Murad, 1983). Subsequent investigation found that a number of 
substances (e.g. norepinephrine, serotonin, vasopressin) were able to induce endothelium-
dependent vasorelaxtion through the same mechanism, providing further credence to the 
pivotal role EDRF played in mediating relaxation of blood vessels.(Furchgott & 
Vanhoutte, 1989) Importantly, during this time, increased amounts of EDRF were shown 
to be released by the endothelium due to increased amounts of shear stress resulting from 
increased blood flow rate both in vitro and in vivo (Griffith, Edwards, Lewis, Newby, & 
Henderson, 1984; Kaiser & Sparks, 1986; Rubanyi, Romero, & Vanhoutte, 1986). These 
findings provided the foundation for the development of an in vivo bioassay for the 
assessment of endothelial-dependent dilation using shear stress as a stimulus.  
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 In 1986, two separate labs, headed by Furchgott and Louis Ignarro, presented 
evidence that EDRF was in-fact nitric oxide (NO).(L. Ignarro, Buga, Wood, Byrns, & 
Chaudhuri, 1987) Through a series of cell culture investigations, both labs concluded that 
NO was the substance produced by endothelial cells, either by a pharmacological agent 
(acetylcholine) or mediated via shear stress. Shortly thereafter, it was found that the 
source of endothelial-derived NO was the byproduct of L-arginine converted into L-
citrulline via an enzyme-mediated reaction. Mediating this reaction was the enzyme 
called endothelial nitric oxide synthase (eNOS), which is a calcium/calmodulin 
dependent oxygenase (Palmer, Ashton, & Moncada, 1988). The use of a catalyst, in this 
case eNOS, is essential for NO production, because the heat of formation is endothermic, 
and in order for molecular nitrogen and oxygen to combine to produce NO, temperatures 
in excess of 1000°C are required. These important steps were necessary for determining 
the mechanism of endothelial-dependent relaxation.  
Mechanism of Shear Stress Mediated Vasorelxation 
 In 1981, Dewley and colleagues described an in-vitro assay for modulating fluid 
shear stress in cultured endothelial cells.(Dewey, Gimbrone, Davies, & Bussolari, 1981) 
This work was based upon previous research which suggested that the endothelium was 
not just a simple barrier but a dynamic system that regulated blood flow and was 
permeable to environmental changes. In their experiment, they found conclusive evidence 
that modulating the hemodynamic environment and exposing isolated endothelial cells to 
fluid shear stress results in change to the physiological function of endothelial cells, in 
contrast to a static medium. They suggested, correctly, that this fluid shear stress system 
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was more akin to normal physiological conditions and could potentially be a more robust 
environment for studying the endothelium as it related to disease. In subsequent 
investigations, the same group noted that both the frequency and amplitude of shear stress 
effected the response of basic endothelial function. Interestingly, they also noted that 
under certain conditions the endothelium showed an adaptive response that shed light on 
how the endothelium may be affected by acute and chronic conditions (P. F. Davies, 
Dewey, Bussolari, Gordon, & Gimbrone, 1984).   
 The mechanism by which fluid shear stress mediated vasorelaxtion is due to a 
complex cascade of events (P. F. Davies, 2009). Shear stress induced 
mechanotransduction (the conversion of mechanical stresses into biological response) is 
central in the regulation of vascular tone. This occurs due to a mechanically stimulated 
release of EDRF’s from the endothelial cells and is mediated by the amount of shear 
forces produced by blood flow. Thus, shear stress is the primary mechanism by which 
endothelial cells produce a number of vasorelaxing substances, including NO. The 
amount of shear is dictated by Poiseuille flow (law), which is a mathematical model that 
dictates that shear stress (τ) is directly proportional to the velocity of blood flow (Q) and 
inversely proportional to the cube of the arterial radius (R). In addition, the viscosity of 
blood (µ) is also taken into account, resulting in the following equation:  
τ = 4µQ/R3 
Therefore, the primary determinant of shear stress is the diameter of the blood vessel in 
which  blood flow and viscosity of blood are contributory factors. However, acute 
changes in either blood flow or viscosity of the blood can substantially alter shear stress.  
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The endothelial cells are lined with mechanoreceptors, which are sensitive to 
changes in shear stress occurring due to blood flow within the vessel. These 
mechanoreceptors, under the presence of increased shear stress, act within the endothelial 
cell to convert mechanical energy into biochemical processes. The mechanoreceptors 
lining the endothelial cells include ion channels, G proteins, tyrosine kinase receptors, 
adhesion proteins, caveolae, cytoskeleton, glycoalyx, and the primary cilia on the cell 
membrane. However, the primary mechanisms for shear induced mechano-signal 
transduction are not fully understood (Ando & Yamamoto, 2009). For example, some 
endothelial cells mechanoreceptors, such as an adhesion molecule platelet endothelial cell 
adhesion molecule-1 (PECAM-1), play a key role in shear-stress mediated 
mechanotranduction in a Akt/PI3K dependent pathway but not a MAPK pathway. This 
suggests that once a mechanotransduction pathway is activated by shear-stress it may or 
may not result in signal transduction by the endothelial cell (Fleming, Fisslthaler, Dixit, 
& Busse, 2005). 
However, to simplify, it can be stated that shear-stress, based on its action in the 
endothelial cell wall, activates a mechanotransduction pathway, whichever it happens to 
be, that activates a cell signaling cascade within the endothelila cell. In turn, this results 
in the eventual activation of eNOS to stimulate the production of NO, which is likely due 
to an integrated response of multiple signaling networks at different subcellular locations 
(Boo et al., 2002; Dimmeler et al., 1999). Once shear-stress mediated 
mechanotransduction has been stimulated, the primary result is the phosphorylation of 
eNOS at Ser
1177
 which activates the enzymes activity (Fisslthaler, Dimmeler, Hermann, 
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Busse, & Fleming, 2000). This allows for the conversion of L-arginine to L-citrulline, in 
which NO is the byproduct of this reaction. Once NO is produced, it can diffuse from the 
endothelial cell into the interstitial space and then into the vascular smooth muscle cell. 
In the vascular smooth muscle NO stimulates its receptor, soluble guanylyl-cylcase 
(sGC), which stimulates the conversion of GMP to cGMP, which induces relaxation of 
the vascular smooth muscle (L. J. Ignarro & Kadowitz, 1985).Therefore, the ability of the 
vascular smooth muscle to relax, allowing for vasodilation, is directly dependent upon the 
effect of shear-stress on the endothelial cell, which plays a key role in vascular tone 
regulation. 
Endothelial Dysfunction in Atherosclerosis  
 Generally, high amounts of shear-stress are beneficial for arterial health, as it 
promotes adaptive structural remodeling within the artery and promotes adaptive dilation 
through endothelium-dependent mechanisms (D. J. Green, Maiorana, O'Driscoll, & 
Taylor, 2004; Mattsson, Kohler, Vergel, & Clowes, 1997). When this process becomes 
deregulated and the endothelium can no longer induce acute or chronic changes in 
vascular tone, vasodilation, and remodeling, an endothelial dysfunctional state has 
occurred. The primary mechanism by which chronic, systemic endothelial dysfunction 
can be defined is the impaired ability of eNOS to either be expressed or activated in order 
to produce NO (Corson et al., 1996; P. F. Davies, 2009). Given that eNOS is primarily 
stimulated in vivo by shear stress, it is likely that endothelial dysfunction results from a 
multifactorial mechanism by which the endothelial cell no longer responds to shear 
stress. Endothelial dysfunction is considered one of the earliest manifestation of the 
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atherosclerotic process, as it occurs even before morphological changes (fatty streaks and 
plaque formation) occur (J. Davignon & P. Ganz, 2004). Thus, endothelial dysfunction 
can be considered a pre-clinical manifestation of the atherosclerotic process. 
Furthermore, endothelial dysfunction declines with increased presence of traditional risk 
factors such as age, smoking, family history, hypercholesterolemia, and high blood 
pressure (D. S. Celermajer, Sorensen, Bull, Robinson, & Deanfield, 1994). Therefore, 
assessment of endothelial function may allow researchers to better define those at higher 
risk for later development of CVD. 
Non-invasive Assessment of Endothelial Function 
Given that the endothelium is only assessable via invasive means, the only 
practical way for endothelial function to become a tool for physiological or clinical 
assessment is through non-invasive means. The development of non-invasive assessment 
of endothelial dysfunction was established in an innovative paper by Celermajer et al., 
which determined endothelial function in conduit arteries (brachial and femoral) using 
non-invasive high-resolution ultrasound after a period of reactive hyperemia (D. S. 
Celermajer et al., 1992). The underlying principle of the technique was to measure the 
diameter of a conduit vessel under resting conditions and then to apply a stimulus that 
would cause the endothelium to respond by inducing vasodilation. As a stimulus, 
Celermajer et al. utilized evidence that laminar and orbital shear stress induced 
endothelial cells to produce NO and developed a means of inducing shear stress in vivo 
by creating reactive hyperemia. Reactive hyperemia is a transient increase in blood flow 
generally due to a physiological response expressing the need to increase oxygen supply 
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to downstream tissues. Therefore, a corresponding increase in reactive hyperemia will 
result in an increase in shear stress. To induce reactive hyperemia in the conduit vessel, 
Celemajer and colleagues induced ischemia in the distal limb by using a blood pressure 
cuff to occlude blood flow for a period of about 5min. After this time period, the cuff was 
released, reactive hyperemia was induced, a corresponding increase in shear stress was 
observed, and a change in arterial diameter could be measured with ultrasound in order to 
determine the amount of vasodilation. After cuff release, they measured conduit vessel 
diameter at 90s and 15s thereafter in order to determine peak response of individuals. 
Using the following equation, they could determine the amount of flow-mediated dilation 
(FMD): 
FMD(%) =  peak diameter  ● baseline diameter     X  100% 
baseline diameter 
 
 Using this technique, they observed that children with familial 
hypercholesterolemia, adult smokers, and those with CVD exhibited significantly less 
FMD compared with “health controls”. The evidence in children was the most important 
finding from the clinical aspect of this study, suggesting that asymptomatic youth with 
risk factors for CVD present reduced FMD despite the lack of clinical manifestation. In 
addition, this study, despite technical flaws that were later corrected in subsequent 
publication (Corretti et al., 2002; Thijssen et al., 2011), provided the foundation for a 
repeatable in vivo assay of endothelial function that could be widely applied to many 
populations.  
 Currently, the recommended guidelines for FMD requires an external stimulus 
(blood pressure cuff inflation >200mmHG below the antecubital fossa) which is used to 
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create ischemia (after 5min of prolonged exposure). Upon cuff release, there is a reactive 
hyperemia response which results in an increase in blood flow through the conduit 
vessels (brachial or femoral), thus, creating an increase in shear stress.  
A full description of the measurement technique used in our lab appears in 
Appendix K with our lab’s reliability in Appendix O. Briefly, measurement of conduit 
vessels is done continuously via high-resolution ultrasound in B-mode. Ultrasound video 
is captured of the lumen of the arterial walls and is measured at both baseline (prior to 
cuff occlusion) and for 3 minutes post-cuff release. Videos are then analyzed using semi-
automated edge detection software which captures the artery diameter and measures it 
continuously for the entire video length, providing an accurate and less-biased approach 
of measurement.(Woodman et al., 2001) Additionally, B-mode ultrasound needs to be 
coupled in duplex with Doppler in order to acquire blood velocity measurements. Duplex 
allows for simultaneous acquisition of vessel diameter and blood flow, which allows for a 
more robust means of assessment.  
In theory, the degree of dilation that occurs can be used as a surrogate for both 
NO bioavailable and reflective of the function of the conduit arteries function.(Pyke & 
Tschakovsky, 2005) A meta-analysis comparing FMD of the same participants using 
either saline or L-NMMA (a NO blocker) infusion showed that FMD was at least 
partially NO-dependent, and with current automated techniques an estimated 67% of 
dilation was accounted for by NO.(D. J. Green, Dawson, Groenewoud, Jones, & Thijssen, 
2014) While the majority of dilation due to shear stress can be accounted for by NO, 
there remains a significant portion of the FMD that  is likely due to other EDRF’s that are 
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stimulated. These may include endothelial derived hyperpolarizing factor (EDHF) and 
prostacyclin, which are both shown to be induced by shear stress.(Bellien et al., 2006; 
Osanai et al., 2000) Additionally, it also supports the hypothesis that vasoconstricting 
agents may be stimulated by shear stress which may hinder the FMD response in the 
presence of a shear mediated response. Both endothelian-1 and angiotensin II, two potent 
vasoconstrictors, are stimulated by shear stress, which may explain the lack of dilation 
under shear stimulated conditions compared with L-NMMA.(Thijssen, Rongen, Smits, & 
Hopman, 2008) 
Risk Factors and Development of Cardiovascular Disease in Youth 
The Bogalusa Heart Study has provided a wealth of epidemiological evidence 
examining the relationship between antemortem CVD risk factors and observed 
morphological atherosclerotic (i.e. fatty streak and plaque formations) development in 
children and adolescents.(Berenson, 2002) In autopsies of 66 persons from birth to age 
26, they observed that traditional risk factors for CVD, particularly TC, LDL, VLDL, and 
blood pressure, were associated (r = 0.36 - 0.62 (age adjusted)) with the earliest stages of 
visible atherosclerotic lesions in both aorta and coronary arteries. (Newman et al., 1991) 
Furthermore, these associations were independent immutable risk factors of age, gender, 
and race. Subsequent studies using the Bogalusa cohort have revealed that not only are 
risk factors associated with the development of fatty streaks and fibrous plaques but as 
risk factors aggregate or cluster so too does the severity of asymptomatic coronary and 
aortic atherosclerosis.(Berenson et al., 1998)   
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While autopsy studies have provided the background to establish that fatty streak 
and plaque development begins in early life and is increased in association with a greater 
number of risk factors, autopsy studies are difficult and provide a low number of subjects. 
Non-invasive techniques for imaging the carotid artery (e.g. common carotid, carotid 
bulb, and internal carotid) have been developed using high-resolution ultrasound 
imaging. The thickness of the regions in the common carotid, carotid bulb, and internal 
carotid are all related to autopsy derived increases in fatty streak and plaque formation. 
(Zarins et al., 1983) Therefore, carotid intima medial thickness (cIMT) provides a means 
of determining arterial wall thickness without cumbersome autopsy studies and gives a 
means of determining the extensiveness of asymptomatic diseases progression. In the 
Bogalusa cohort, cIMT was shown to increase with a greater number of risk factors 
(family history, blood pressure, obesity, lipoproteins, insulin, glucose, and smoking), 
similar to that of autopsy studies.(Berenson, 2002) Interestingly, the increase in cIMT 
appeared to be in a dose-dependent manner, highlighting the effect of clustering of risk 
factors. Together, these data suggest that risk factors are associated with presence and 
progression of the morphological manifestations for CVD. Furthermore, the use of risk 
factors may likely provide an opportunity to identify youth at the highest risk for CVD 
development. 
Evidence provided by the Cardiovascular Risk in Young Finns Study has 
extended the vast work of the Bogalusa heart study and added the assessment of 
endothelial function (FMD) to their cohort. The Cardiovascular Risk in Young Finns 
Study is a large cohort (n > 3000) longitudinal study in Finland that has measured CVD 
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risk factors in youth (aged 3-18yr old) and followed them with subsequent measurement 
later in early adulthood (aged 24-39yr old) in order to investigate the early childhood 
factors that might be associated with increased presence of CVD risk later in senescence. 
This study has been instrumental in providing epidemiological data on the relationship 
between endothelial function and childhood/early adulthood characteristics.  
The Young Finns Study observed that endothelial function is associated with 
increased cIMT and that association is enhanced with increased presence of traditional 
CVD risk factors (M. Juonala et al., 2004). This suggests that endothelial dysfunction 
may compound the effect of traditional risk factors by enhancing or speeding up the CVD 
process as observed by increased levels of cIMT. Additionally, this study showed that 
increases in systolic blood pressure in adolescent (12-18 yr old) were associated with 
reduced endothelial function in early adulthood (M. Juonala et al., 2006).This is likely the 
effect of systemic shear stress increases over an extended duration, which is likely to 
result in a decrement in endothelial function through multiple mechanisms of action 
(Vanhoutte, 2009). Furthermore, they observed that gender effects on endothelial 
function are likely the result of males presenting increased artery diameter and that the 
effect of gender is lost when traditional risk factors are taken into account (M Juonala et 
al., 2008).Therefore, these data suggest that in order to preserve or enhance endothelial 
function from youth into adulthood prevention of increased traditional CVD risk factors 
may be essential.   
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Cardiovascular Disease Risk and Obesity  
 Obesity has increased in prevalence in the United States as well as other countries 
around the world since the 1970s. Current estimates suggest that in the United States 
~32-35% of adults and ~17% of youth are obese (Flegal, Carroll, Kit, & Ogden, 2012; 
Ogden et al., 2012). These trends have leveled off in recent years and there have been no 
increases in overall obesity. However, whether obesity is associated with an increase in 
mortality remains a controversial issue. Flegal and colleagues suggest that obesity only at 
the highest ends of the BMI spectrum (≥35 kg/m2) are associated with an increase in all-
cause mortality. With class 1 obesity (BMI= 30-35 kg/m
2
) may not be associated with an 
increase in mortality and overweight adults (BMI= 25-30 kg/m
2
) exhibiting the lowest 
risk of all-cause mortality. These data suggest that overweight and obesity at its lowest 
ends (25-35 kg/m
2
) are not associated with increased risk of mortality; however, those at 
the highest end of the BMI spectrum are at increased risk. It should be noted that this 
association between obesity and mortality is not without controversy (Flegal, Kit, & 
Graubard, 2013). 
Obesity has been associated with a number of chronic disease conditions 
including CVD. The Framingham Heart study was one of the first to show that increases 
in obesity (as measured by body weight) was associated with an increased number of 
CVD events (Hubert, Feinleib, McNamara, & Castelli, 1983). However, important 
confound variables, such as lifestyle factors, were not taken into account in this very 
homogenous cohort.  Additionally, it is important to note that this relationship is not 
linear.  In fact there is a J or U shaped relationship which shows that person at both the 
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low and the high end of the BMI-spectrum exhibit increased disease risk, CVD, and all-
cause mortality.  Perhaps the best meta-analysis on the topic was published by Romero-
Corral et al, they combined the results of 40 large cohorts, with 250,152 patients with a 
mean follow up of 3-8 yrs (Romero-Corral et al., 2006).  This study demonstrated a U-
shaped relationship for total mortality and cardiovascular mortality, both adjusted and 
unadjusted for confounding variables. They demonstrated, in their adjusted model, that 
overweight persons had the lowest risk of all-cause mortality (RR: 0·87 [0·81–0·94]), 
whereas obese and severely obese people had no increase in risk (RR: 0·93 [0·85–1·03] 
and 1·10 [0·87–1·41], respectively).  However, they did note that severely obese persons 
had significantly elevated risk of CVD mortality (RR=1·88 [1·05–3·34]).  These findings 
suggesting that those at the highest end of the BMI-spectrum should be the primary focus 
of studies which aim to reduce the burden of CVD risk associated with obesity.   
There is substantial evidence to support that reasonable levels of physical activity 
or cardiorespiratory fitness ameliorate chronic disease conditions associated with obesity 
(Lee, Sui, & Blair, 2009). Prospective data from the Aerobics Center Longitudinal Study 
(ACLS) first showed that low levels of physical fitness were associated with increased 
risk of all-cause mortality and CVD events (Blair et al., 1995; Blair et al., 1989). 
Interestingly, studies from the ALCS have also shown that changes in fitness were the 
best predictor of mortality risk, regardless of baseline fitness levels. This suggests that 
improving or maintaining fitness levels is the best way to reduce mortality risk. Further 
investigation from the ALCS and others have shown that fitness may counteract the 
effects of obesity on mortality risk wherein obese fit persons show no elevated risk for 
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all-cause mortality (Barry et al., 2014). Together these data suggest that, obesity at the 
highest end of the BMI spectrum is associated with an elevated risk for CVD and all-
cause mortality. However, when important confounding variables are taken into account, 
particularly fitness, obesity appears to be relatively benign until you reach higher ends of 
the BMI spectrum.     
Obesity and Cardiovascular Disease Risk in Youth 
 Due to the long-latent period between elevated CVD risk and development of 
overt CVD disease it is difficult to determine whether obesity in childhood will result in a 
corresponding increase in CVD events and/or mortality in adulthood. The current body of 
literature would suggest that there are associations between overweight and obesity and 
childhood and adolescence and premature mortality and morbidity. A systematic review 
by Reily and Kelly found that 4 out of 5 studies, which examined overweight/obesity in 
childhood, showed an increased risk of premature mortality. In studies (n=11) where 
cardiometabolic morbidity (diabetes, hypertension, stroke, CHD) were available, they 
found that obesity in youth was associated with an increased risk of cardiometabolic 
morbidity ranging from 1.1-5.1 fold risk (Reilly & Kelly, 2011). The findings were 
consistent between studies despite differences in nationality and sample sizes. It should 
be noted that none of the studies included in the review were able to account for lifestyle 
factors, which may have impacted the results. Nevertheless, these data suggest that 
obesity in youth may lead to an increased risk of morbidity and may reduce life 
expectancy.  
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 Due to the difficulty in examining the longitudinal association between childhood 
issues and their corresponding effect in later life, risk factors for disease are often used. 
Obesity in youth is associated with a number of risk factors for CVD and these risk 
factors tend to increase in accordance with increases in BMI regardless of age or gender.  
Data from the Bogalusa heart study shows that as obesity increases there is a dose-
response relationship between the degree of obesity and number of CVD risk factors 
(Freedman, Mei, Srinivasan, Berenson, & Dietz, 2007).  With those above the 97
th
 
percentile being at the highest risk, and showing an exponential increase once obesity 
reaches the 99
th
 percentile.  These data suggest that targeting intervention in those at the 
extreme end could yield the greatest benefits and make the largest impact on future 
disease burden.  
Obesity and Endothelial Function in Youth 
 Most studies have observed that obese youth have significantly lower endothelial 
function in comparison with lean, healthy counterparts (Farpour-Lambert et al., 2009; C. 
L. Kaufman, Kaiser, Steinberger, & Dengel, 2007; Meyer, Kundt, Lenschow, Schuff-
Werner, & Kienast, 2006). However, it should be noted that several studies used sub-
standard methodology. While their findings were published in peer-reviewed journals, 
substantial technical/standardization progress has been made since Celermajer et al. 
published their landmark paper (D. S. Celermajer et al., 1992).Therefore, in an effort to 
review the most current and up-to-date data regarding the relationship between obesity 
and endothelial function in youth, only studies which measured FMD using the current 
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guidelines and utilizing edge-detection software (Harris, Nishiyama, Wray, & 
Richardson, 2010; Thijssen et al., 2011). 
 Prior to puberty, obesity in children has been shown to reduce endothelial 
function. Farpour-Lambert observed that obese children had significantly lower FMD 
(n=22, FMD = 4.1%, 95%CI 3.7-4.8%) than lean controls (n=22, FMD = 7.8%, 95%CI 
7.1-9.5%) (Farpour-Lambert et al., 2009). In conflict with these findings, a population 
based study by Charakida and colleagues which found no significant difference between 
normal-weight and obese children. Examining a cohort of 6,576 children aged 10-11 
years old (10.6±0.1%), they found no difference in FMD between normal weight 
(8.1±3.3%), overweight (8.1±3.4%), and obese youth (8.2±3.2%). The authors suggested 
that perhaps obesity, prior to puberty, may not impact endothelial function despite 
observed increases in many other CVD risk factors with obesity (Charakida et al., 2012). 
While this study is very strong in methodology and in terms of sample size, it is limited 
by the small amount (4%) of obese youth in the cohort. However, these findings suggest 
that obesity, at least prior to age 11, may not impact endothelial function when observed 
at a population level versus that of a clinical setting, as in the Farpoup-Lamert et al. 
findings.  
In adolescents, more studies have examined the effects of obesity on endothelial 
function. Meyer et al. observed significantly reduced FMD in obese adolescents 
(4.79±1.76%) versus their lean counterparts (10.65±2.0%, p<0.001). In accordance with 
these findings, Watts and colleagues showed that FMD was significantly impaired in 
obese adolescents relative to lean controls (5.3 ± 0.9% to 8.9 ± 1.5%, p < 0.05). These 
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data suggest that obesity during adolescence may contribute to reduced endothelial 
function. However, these sample sizes are relatively small, n=34 and n=20 respectively. 
One study in obese adolescents observed no significant difference between lean and 
obese adolescents with respect to FMD (Naylor et al., 2011). This study by Naylor et al. 
did find that obese adolescents with type 2 diabetes exhibited reduced FMD (p<0.05). 
This suggests that insulin resistance may play a vital role in endothelial dysfunction in 
youth, which is not accounted for in any studies to date. More population based samples 
are needed to define the role of obesity on FMD. It is likely that obesity per se may not be 
the only contributing factor to the reduced endothelial function observed, findings which 
cannot be examined in small cohorts. Furthermore, additional work needs to be done in 
order to define the roles of extraneous factors that may impact both obesity and 
endothelial function.   
Significant associations have been observed between adiposity and FMD. 
Kaufman et al showed that FMD was significantly and inversely associated with body 
fatness as measured by DXA (r = -0.34, p<0.05) in children (11.5±0.1 yr old) (C. L. 
Kaufman et al., 2007). Suggesting that body composition may play an important role in 
endothelial function; whether this is independent of obesity status is unknown. 
Heritability of FMD has been examined in cohorts of twins with an estimated  44% of the 
variability in FMD explained by genetic factors (Hopkins et al., 2010). This study 
suggests the potential roles of pre- and peri-natal influences on endothelial function 
which have yet to be examined. While aging is associated with increased arterial diameter 
(Sarkola et al., 2012) and pubertal onset insulin resistance is a common phenomenon, 
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puberty does not appear to impact endothelial function in youth (Marlatt et al., 2013). 
However, the role of insulin resistance and endothelial function in youth has yet to be 
defined, despite the substantial mechanistic evidence of its role (Muniyappa, Montagnani, 
Koh, & Quon, 2007). Thus, while obesity may play a role in reducing endothelial 
function, many other factors need to be considered and further research is needed in order 
to define the specific mechanism by which obesity alone inhibits endothelial cell 
function.   
Exercise Training and Endothelial Function 
 Lifelong physical activity is associated with decreased mortality and reduced 
CVD events, in adults.(Blair et al., 1989; Paffenbarger, Hyde, Wing, & Hsieh, 1986) 
Exercise training has been shown to reduce risk for CVD with improvements in 
endothelial function being a potential mediating mechanism. Perhaps the best evidence to 
support the efficacy of exercise as a means of improving endothelial function comes from 
Hambrecht and colleagues,  they examined the effects of a 4-wk moderate intensity 
exercise program on patients with stable coronary artery disease (Hambrecht et al., 2003). 
Training improved in vivo and in vitro acetylcholine (ACh) responses and adenosine-
mediated blood flows, indicating that both conduit and resistance artery endothelium 
dependent vasodilator function were enhanced. Training also resulted in increased eNOS 
mRNA, eNOS protein expression, and shear stress related eNOS phosphorylation, 
supporting that a shear stress dependent mechanism may be responsible for the enhanced 
NO bioactivity with training. While the intensity of exercise was moderate ~70% of HR 
max, this suggests that with training even moderate intensity exercise can result in major 
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improvements in vasodilator capacity. This is even true in short periods of time (7 days; 
60 min/d; 60% VO2max) as exercise training has been shown to improve femoral blood 
flow in type 2 diabetics (Mikus et al., 2011). Thus, exercise training may improve 
vascular function in various populations and of various time-lengths. 
Improvements in vascular function have been shown in obese children undergoing 
an 8-week exercise training. The exercise consisted of a circuit training program which 
combined moderate-vigorous aerobic and moderate resistance training. After 8-weeks, 
the endothelial dysfunction associated with obesity in children was ameliorated, in which 
the vascular function of the obese children was the same as the lean control (Watts, Beye, 
Siafarikas, Davis, et al., 2004). In addition to the functional changes of the vasculature 
that occur with exercise, structural changes also take place. Arterial remodeling occurs in 
large conduit vessels due to exercise training. This has been observed in cross sectional 
studies where trained endurance athletes had larger conduit arteries than sedentary 
controls.(D. J. Green et al., 2013) 
  While the specific mechanisms of arterial remodeling are not elicited yet, there is 
growing evidence to support that chronic changes in shear stress induce arterial 
remodeling that is endothelium and NO dependent. Therefore, it is plausible that arterial 
remodeling may occur in a shear-stress dependent manner. Furthermore, exercise modes 
which promote higher shear rates may elicit greater vascular adaptations. It is important 
to note that the specific mechanisms and exercise intensities which contribute to arterial 
remodeling are not yet understood. However, the time course of remodeling is thought to 
take place between 4-8weeks after starting an exercise training program (D. Green, 
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2009).  This results in a research predicament as remodeled arteries often have a reduced 
FMD due to increased vessel diameter.  Whether improvements are achieve through 
remodeling or increases in function, it should be recommended that adoption of any 
exercise training program may elicit positive effects on vascular function in high-risk 
populations.   
Postprandial Metabolism and Endothelial function 
Although most recommendations for assessment of cardiovascular risk factors, 
including endothelial function, suggest that testing occur after a prolonged fast,(Kavey et 
al., 2006; Thijssen et al., 2011) this state may not reflect the true physiologic nature of the 
vascular system in relation to health and disease (F. Kaufman, 2005). Humans spend 
most of their waking time in the postprandial state, and postprandial dysregulation of 
carbohydrate and fat are critical pathophysiologic processes underlying CVD 
(Ebenbichler et al., 1995; Tushuizen et al., 2005).   
Several studies have examined the effects of various meal compositions on 
postprandial endothelial function in adults with mixed results. Ayers et al., gave 7 health 
normal weight and 7 healthy obese young adults (32±6 yrs) a standardized high-fat meal 
consisting of 60g of fat and 1000kcal (Ayer, Harmer, Steinbeck, & Celermajer, 2010).  
They measured FMD along with other vascular reactivity measures at 1 hour and 3 hours 
post-meal ingestion.  Despite consuming the high-fat meal, they observed no change in 
FMD from baseline to 3hr post-meal in either the normal-weight (4.7±4.1 to 4.3±3.9%) 
or obese group (6.2±1.7 to 5.8±4.3%, p(group*time) = 0.975).  They additionally observed 
no difference in any other measures of vascular reactivity. Similarly, de Roos and 
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colleagues, observed no change in FMD at 3 hours post-meal (2.62 to 3.00%, p=NS) in 
healthy men (>35 yrs old, BMI = 25.4±2.6 kg/m
2
) after consuming a high fat meal (1178 
kcal, 79g fat) (de Roos et al., 2002). The de Roos study should be taken with a cautionary 
note, that the FMD’s observed were considerably lower than that of other investigation, 
and current standardized methods of FMD assessment were not able to be adhered to.   
The mechanism of the lack of impairment in vasodilation due to a mixed-meal 
observed in these studies in not well understood.  Raitakari and colleagues, examined the 
effect of two high-fat meals (1030kcal, 61g fat) with differing fatty acid compositions in 
12 normal-weight/overweight men and women (33±7yr, BMI = 24.3±3.1 
kg/m
2
)(Raitakari et al., 2000). The observed no change in FMD at 3 hours or 6 hours 
post-meal in either meal.  However, they did observe that with either meal, participants 
had an increase in forearm blood flow, increased triglycerides and increased insulin at 3 
hours, in response to the meal.  The increase in forearm blood flow was highly associated 
with the insulin response observed (r = 0.80, p<0.002).  The authors suggested that the 
hyperinsulinemia response observed in the postprandial state mediated changes in 
forearm blood flow which may counter-act any detrimental effects of that meal on 
endothelial function.  
 Despite these studies, several studies have shown the ability of high-fat meal to 
induce endothelial dysfunction in adults (Jackson, Armah, & Minihane, 2007). Cortes et 
al., examined the effect of 2 high-fat meals (~1200kcal, 63% fat; 1 with walnuts (40g), 1 
with olive oil (25g)) on endothelial function 4hrs post meal in healthy normal-weight 
controls (n=12, 32±8yr old, BMI=24.7±3.0)  and those with hypercholesterolemia (n=12, 
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45±13yr old, BMI=26.3±3.5). (Cortes et al., 2006)  They observed that neither meal 
reduced endothelial function in the controls, while the meal which was high-fat with olive 
oil significantly reduced FMD in the hypercholesterolemia group (3.6±1.3 to 2.3±2.2, 
P=0.006).  They did however observed no reduction in the hypercholesterolemia group 
with walnuts in the meal.  These data suggest that healthy adults may not be as prone to 
the effects of a high-fat meal on postprandial endothelial function, while persons a high 
risk for CVD may be more effected. 
 In support of this concept, Johnson and colleagues examined the effects of a high-
fat meal on postprandial endothelial function in physically inactive and activity normal-
weight, healthy young adults. FMD was measured at fasting and 4hrs post-meal (940kcal, 
46%fat).  They observed that while the active individuals were protected against 
endothelial dysfunction at 4hrs post-meal, the inactive persons exhibited significant 
endothelial dysfunction (p=0.02) (Johnson, Padilla, Harris, & Wallace, 2011).  
Studies, in a non-mixed meal setting, which utilize oral and intravenous fat 
challenges have been successful at inducing endothelial function.  In a study of 13 obese, 
healthy adults (32.2±9.8yr, BMI= 36.7±5.1) Gosmanov et al., provided evidence that fat 
loads, whether received intravenously or orally, impair endothelial function at 4hr and 
8hr after being given (Gosmanov, Smiley, Robalino, Siqueira, et al., 2010). They gave 
participants 2 different oral fat loads as an emulsion (low fat = 32g, high fat = 64g; 100% 
fat load) at equal doses every 2hours over 6 hours. They observed significant decreases in 
FMD from baseline in both meals at 4hr and 8hrs, with a relative decrease in FMD of 
38% for low fat and 51% for high fat (Pboth<0.001).  They had similar findings with the 
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intravenous lipid infusions and there data suggest that a pure oral fat load impacts 
endothelial function. However, mixed-meals appear to be more physiologically relevant 
and therefore need to be further evaluated in their efficacy. Moreover, postprandial 
studies offer a unique opportunity to examine whether endothelial function can be 
improved in a more relevant period of the day. 
Acute Exercise and Postprandial Endothelial Function in Adults 
 Acute exercise, especially high-intensity exercise, has been shown to increase  
markers of inflammation and oxidative stress (K. J. Davies, Quintanilha, Brooks, & 
Packer, 1982). Thus, there may be an acute impairment following exercise on vascular 
function, as inflammation and oxidative stress have been shown to acutely impair NO-
mediated vasodilator function. However, this acute effect of exercise is biphasic, wherein 
a transient negative period of vascular stress occurs immediately after exercise, followed 
by a prolonged positive phase (Haram et al., 2006). Therefore, the time course of acute 
exercise must be examined in order to fully understand the impact of exercise on vascular 
function. To investigate the effects of a prolonged intense bout of exercise, Dawson et al. 
examined the vascular function of fifteen men pre- and post- a marathon (42.2 
km).(Dawson et al., 2008) The researchers examined conduit artery function of the 
brachial artery and femoral artery within 1 hour post-race. They found that while brachial 
conduit artery function remained the same, there was a significant reduction in femoral 
artery function post-exercise. From this study, we can gather that acute exercise of 
prolonged duration >3hrs, which will be largely vigorous throughout, may impair 
vascular function acutely in local site of maximal flow. Data from Haram et al. confirms 
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these findings. However, they found that while this effect exists for the 1st hour, at 6 
hours post-exercise this impairment no longer exists and that an improvement in vascular 
function is seen for up to 192 hours post-exercise. Further, they showed that this 
relationship exists for both exercise trainers and sedentary controls, wherein trained 
individuals show the greatest benefits, but both groups showing improvement. Thus, it 
can be taken that acutely (less than 6hours) there is an impairment of vascular function, 
but this is followed by a substantially prolonged period by which vascular function is 
improved. 
Gill and colleagues were the first to observe that acute exercise may protect 
against endothelial dysfunction induced after a high fat meal (J. M. Gill et al., 2004).  
They examined the effects of a high-fat meal challenge on endothelial function as 
measured by Peripheral micro-vascular function using acetylcholine infusion. Twenty 
participants (10 lean (waist <90cm), 10 centrally obese (waist >100cm)) completed 2 
visits, in which one was with prior exercise (14-16hrs, 90min walking at 50% VO2peak) 
and one was without prior exercise. Participants were given a fixed high-fat meal (80g 
Fat, 70g CHO, 12g PRO, 1027kcal) and endothelial function was measured every 2 hrs 
post-meal for 8hrs. They observed no difference between lean and obese adults. When 
groups were combined, they observed that exercise improved fasting endothelial function 
(+25%, p=0.02). They also observed that endothelial function was significantly elevated 
at each time point (p<0.01), in which an overall response was 15% greater than the 
control condition (p=0.048). It should be noted that while peripheral micro-vascular 
function is a validated technique, it does not measure dilatory capacity; rather, it assesses 
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skin profusion. Whether this is applicable to conduit artery function cannot be determined 
by this study. Despite this limitation, this study provided the framework for exercise to be 
examined as a potential means of improving fasting and postprandial endothelial 
function.  
 In a subsequent study, Padilla et al. using FMD examined whether exercise after 
consumption of a high-fat meal could protect against endothelial dysfunction induced by 
a high-fat meal. Eight participants (5 males, 3 females; 25.5±0.8 yrs old, BMI = 22.8±0.6 
kg/m
2
) completed 3 challenges. One low-fat meal (0g Fat, 209g CHO, 23g PRO, 
945kcal), one high-fat meal (48g Fat, 91g CHO, 33g PRO, 940kcal), and one high-fat 
meal with exercise 2hrs post ingestion (45min walking at 60% VO2peak). They measured 
FMD at fasting and at 4 hours and observed that the high-fat meal induced endothelial 
dysfunction while the low-fat meal did not. Importantly, the exercise protected against 
the postprandial endothelial dysfunction (p<0.01) from the high-fat meal. These findings 
suggest that exercise has the ability to improve endothelial function despite the presence 
of a high-fat meal and that a low-fat meal not inhibit endothelial function.  However, 
whether exercise prior to a high-fat meal can protect against postprandial endothelial 
dysfunction needed to be further investigated.  
 Tyldum et al. examined the effect of high-intensity exercise versus continuous 
exercise prior to a high-fat meal on postprandial endothelial function. Eight healthy men 
(42±4 yr old, BMI = 28.8±0.9 kg/m
2
, VO2peak 52.6±2.6) completed 3 visits. On each 
visit, participants consumed a high-fat meal (48.3 g fat, 80.4 g CHO, 38.5 g PRO, 911.2 
kcal). In addition to a no exercise prior control, 2 visits were preceded by treadmill 
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exercise 16 hours prior, including a high-intensity interval exercise bout (4 X 4 min at 85-
95% HRmax with 3 min of active recovery between bouts, 47min total) and a continuous 
moderate exercise (60-70% HRmax for 47min). They observed that continuous exercise 
improved fasting endothelial function and sustained endothelial function in comparison to 
a high-fat meal control, which showed dysfunction at 2hrs and 4 hrs post-meal. The high-
intensity interval exercise improved fasting endothelial function beyond that of either 
control or continuous exercise. In addition, the high-intensity interval exercise exhibited 
significantly higher endothelial function throughout the entire meal challenge. This study 
was the first to demonstrate the protective effects of exercise prior to a high-fat meal on 
postprandial endothelial function using FMD. Taken together, these studies suggest that 
exercise whether given prior or after a high-fat meal, protects against postprandial 
endothelial function. 
Acute Exercise and Postprandial Endothelial Function in Youth 
 To date there have only been limited investigation into whether exercise can 
protect against postprandial endothelial dysfunction in youth. Sedgwick and colleagues 
were the first to examine whether exercise is able to protect against postprandial 
endothelial function in youth.(MJ Sedgwick et al., 2013) They provided youth with 2 
meals (breakfast and lunch) and measured FMD at fasting, 3 hours, and 6 hours after 
consumption of the first meal. For breakfast, youth consumed a chocolate milkshake of 
92.9 kJ/kg body weight (22.2 kcal/ kg body weight), which was 60% Fat, 33% CHO, and 
7%PRO. After the 3 hour FMD was taken, a cheese sandwich 84.6 kJ/kg body weight 
(20.2 kcal/kg body weight) 50% Fat, 37% CHO, and 13% PRO was consumed. Thirteen 
32 
 
healthy, adolescent males (13.6±0.6 yrs old, BMI=22.3±4.2 kg/m
2
, VO2peak = 48.1±7.5 
ml/kg/min) completed 2 visits, including an prior exercise bout (~14hr) and another 
without prior exercise. The exercise consisted of four, 15 min walking periods at 60% of 
VO2peak, which included 3 min of rest between bouts. They observed no differences in 
fasting FMD was observed (p=0.449). However, the researchers observed that exercise 
was able to protect against postprandial endothelial function at both 3 hours and 6 hours 
post meals (p<0.05).(MJ Sedgwick et al., 2013)      
 In a subsequent investigation by the same group, Sedgwich et al.used an identical 
meal design with differing exercise stimulus and confirmed their findings in a similar 
population. (MJ. Sedgwick, Morris, Nevill, & Barrett, 2014) They split 60min of exercise 
into 6 x 10 min of bouts throughout the day with 50min of rest between each bout. Each 
10min bout was at 70% of VO2peak on a treadmill. Fourteen adolescent males (12.9±0.7 
yrs old, BMI=20.3±3.5 kg/m
2
, VO2peak=45.4±7.9) completed 2 study visits, measuring 
FMD at fasting, 3 hours, and 6.5 hours post-meals. At fasting, they observed no 
difference in FMD; however, at 3 hours and 6.5 hours post-meal, the exercise was able to 
protect against postprandial endothelial dysfunction observed in the meal only condition 
(p<0.001). Combined, the Sedgwick et al. studies suggest that exercise, whether given as 
a single dose or spread throughout the day, can protect against postprandial endothelial 
dysfunction in healthy, normal-weight adolescent males.  
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Definition of Terms 
Pediatric Obesity: We will define pediatric obesity using criterion established by the 
Center for Disease Control, which uses body-mass index percentile based on age, gender, 
height, and weight. These criterions state that individuals who are greater than or equal to 
the 95
th
 percentile for their respective age and gender category are defined as Obese.  
High-Intensity Interval Exercise: A single exercise bout characterized by short (6 
seconds to 6 minute) periods of exercise at an intensity level just below maximal exertion 
and separated by low-intensity recovery or active rest periods.  
Shear Stress: The frictional force created by flowing blood across the endothelial cell 
surface. 
Endothelial Function: Ability of the endothelial cell, a single monolayer which lines 
arteries, to produce endothelial-derived relaxing factors, primarily nitric oxide, to 
stimulate smooth muscle relaxation and vasodilation.  
Brachial Artery Flow-mediated Dilation: Ability of an artery to dilate after reactive 
hyperemia, induced by ischemia, produces shear stress, which creates NO and results in 
an endothelium-dependent vasodilation that can be measured using high-resolution 
ultrasound. 
Postprandial Endothelial Dysfunction: The inability of the endothelium to function 
properly after the ingestion of a meal, resulting in a dilation that is less than baseline 
fasting values. 
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CHAPTER 3: STUDY INTRODUCTION 
Rationale 
 Pediatric obesity represents one of the most significant public health 
challenges facing our society. Obesity in youth is associated with increased 
cardiometabolic morbidity and premature mortality (Reilly & Kelly, 2010), and most 
obese youth will become obese adults (Freedman et al., 2005). Obese youth, particularly 
those at the higher end of the BMI spectrum (i.e. those above the 97
th
 percentile), are at 
increased risk for developing cardiovascular disease (CVD) and type 2 diabetes (T2D) 
(Bacha F, 2006; Srinivasan SR, 2006). Up to 30% of youth > 97
th
 percentile exhibit the 
metabolic syndrome, which tracks into adulthood and predicts the development of CVD 
and T2D (Cook et al., 2003; Morrison et al., 2007; Rodriguez et al., 2006). This is further 
exacerbated by the fact that adolescents > 97
th
 percentile are the only growing population 
of obese youth (Ogden et al., 2012), making this population of youth an optimal target for 
intervention.  
Cardiovascular Disease Risk: Role of Endothelial function 
A major challenge to addressing cardiovascular health in youth is the long latent 
period between elevated cardiovascular risk and future cardiovascular outcomes. 
Although the atherosclerotic process begins in childhood, for the most part, it remains 
subclinical for a number of years (Newman et al., 1991). Impaired endothelial function 
(i.e. endothelial dysfunction) is one of the earliest manifestations of atherosclerosis, (Jean 
Davignon & Peter Ganz, 2004). When non-invasive techniques to assess subclinical 
atherosclerosis are applied to the pediatric population, they clearly illustrate that early 
atherosclerotic processes are compounded by adiposity, insulin resistance, and 
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hyperglycemia in youth (Urbina et al., 2009). Several studies suggest that obesity is 
independently associated with endothelial dysfunction in youth, but very few studies have 
evaluated whether endothelial dysfunction can be reversed via exercise in this population 
(Aggoun et al., 2008; Mahmud et al., 2009; Woo et al., 2004). 
Exercise and Cardiometabolic Disease Risk in Youth 
In addition to obesity, declines in physical activity levels which are observed 
throughout childhood, are thought to contribute independently to increased chronic 
disease risk, including endothelial dysfunction (Trigona et al., 2010; Trost et al., 2002). 
Although lifestyle modifications represent the cornerstone of weight management in 
youth, very few successful pediatric obesity treatments are currently available (Whitlock, 
O'Connor, Williams, Beil, & Lutz, 2010). Unfortunately,  most studies in youth focus on 
adiposity as the outcome of interest (Dietz, 2005), and only a small number include 
measures of subclinical atherosclerosis (e.g endothelial function) as endpoints (Fernhall 
& Agiovlasitis, 2008). Therefore, there is a pressing need for better programs that address 
the increases in cardiometabolic disease risk observed with obesity and inactivity which 
utilize proximal indicators of vascular health.   
Intensity-dependent Recommendations 
Current American College of Sports Medicine (ACSM) recommendations for 
physical activity in adults acknowledge the benefits of vigorous-intensity physical 
activity for promoting and maintaining health (Haskell et al., 2007). Additionally, these 
recommendations acknowledge recent advances in science and suggest that vigorous-
intensity exercise may have a more robust benefit for reducing CVD and premature 
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mortality than moderate-intensity exercise. In contrast to the adult literature, current 
physical activity guidelines for youth (W. B. Strong et al., 2005) are limited by 
insufficient science and a lack of evidence concerning the effects of physical activity on 
cardiovascular health, as most studies focus on adiposity as the outcome of interest 
(Dietz, 2005). Therefore, more evidence is needed in order to determine what intensities 
of exercise are most beneficial in youth, and more effective exercise prescriptions are 
needed in order to optimize reductions in long-term disease risk among youth. Moreover, 
these exercise prescriptions should lead to clinically measurable improvements in health 
indicators beyond adiposity.  
Exercise as Vascular Medicine  
To date, the few studies that have utilized exercise as medicine for endothelial 
dysfunction in youth have focused exclusively on endothelial function under fasting 
conditions (Kelly et al., 2004; Watts, Beye, Siafarikas, O'Driscoll, et al., 2004). Although 
most recommendations for assessment of cardiovascular risk factors, including 
endothelial function, suggest that testing occur after a prolonged fast (Kavey et al., 2006; 
Thijssen et al., 2011), this state may not reflect the true physiologic nature of the vascular 
system in relation to health and disease (F. Kaufman, 2005). Humans spend most of their 
waking time in the postprandial state, and postprandial dysregulation of carbohydrate and 
fat are critical pathophysiologic processes underlying CVD and T2D (Ebenbichler et al., 
1995; Tushuizen et al., 2005). Furthermore, it is clear that regular physical activity is 
cardioprotective, but the greatest benefit of exercise on cardiometabolic health may be 
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observed during the postprandial state due to endothelial adaptation (Graham, 2004; 
Haram et al., 2006). 
 
Exercise and the Postprandial State 
Evidence in adults suggests that exercise attenuates postprandial lipemia 
(Katsanos, 2006) and improves endothelial function (J. M. R. Gill et al., 2004). However, 
the majority of these studies use continuous exercise at a moderate intensity (i.e. 
traditional exercise) as the exercise prescription. Recent evidence suggests that, in adults, 
high-intensity exercise is more beneficial in improving markers of CVD, including 
endothelial function, than a traditional clinical approach (Gaesser & Angadi, 2011; 
Gibala et al., 2012). These data are accompanied by evidence that high-intensity exercise 
prior to a high-fat meal completely ameliorates high-fat meal induced postprandial 
endothelial dysfunction (Tyldum et al., 2009). Nevertheless, despite the increasing 
literature to support intensity-dependent benefits of exercise on cardiovascular outcomes, 
(Tanasescu et al., 2002) very few studies incorporate high-intensity exercise in youth 
(Ingul et al., 2010). 
Youth and High-intensity Exercise 
Interestingly, younger populations may be better suited for high-intensity exercise 
than adults, because children and adolescents exhibit greater resistance to fatigue in 
response to repeated bouts of high-intensity exercise (Ratel, Lazaar, Williams, Bedu, & 
Duché, 2003). Additionally, during high-intensity exercise, children exhibit an ability to 
reach a steady state of oxygen consumption faster than adults, and children experience 
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less oxygen drift during high-intensity exercise than adults (Armon, Cooper, Flores, 
Zanconato, & Barstow, 1991). This lack of oxygen drift may explain why children 
experience lower lactate levels at similar workloads than adults (Eriksson, 1980), which 
makes children a prime population to utilize high-intensity type exercise.  
Despite this evidence, no studies have examined whether high-intensity interval 
exercise can improve measures of endothelial function in high-risk youth in either a 
fasted or postprandial state. As more obese youth are increasingly referred for treatment 
(Force), high-intensity interval exercise may offer clinicians  an exercise prescription that 
is well-tolerated and more efficacious at improving cardiovascular health in this patient 
population. 
In order to respond to the growing epidemic of obesity in youth, translational 
research on the effects of exercise on cardiovascular health is needed. Compiling this 
evidence using defined protocols and proximal indicators of vascular health is an 
essential step towards developing exercise prescriptions for disease prevention 
approaches.  
Significance 
Obesity in youth is associated with increased cardiometabolic morbidity and premature 
mortality (Reilly & Kelly, 2010), and most obese youth will become obese 
adults.(Freedman et al., 2005) Recent projections suggest that by the time today’s youth 
enter the workforce, obesity will account for as much as $956 billion dollars or 16-18% 
of the total US health-care costs (Wang, Beydoun, Liang, Caballero, & Kumanyika, 
2008). Much of the increased costs are due to obesity-related diseases such as CVD and 
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T2D, which have antecedents early in life (Freedman, Dietz, Srinivasan, & Berenson, 
1999). Approximately 90% of obese youth exhibit at least 1 CVD risk factor (Cook et al., 
2003), and this is exacerbated by incremental increases in obesity (Freedman et al., 
2007). When non-invasive techniques to assess subclinical atherosclerosis are applied to 
the pediatric population, they clearly illustrate that early atherosclerotic processes are 
compounded by adiposity, insulin resistance, and hyperglycemia in youth (Urbina et al., 
2009). These findings underscore the urgency for addressing cardiometabolic health in 
targeted populations of obese youth and highlight the importance of proximal measures 
of vascular health and subclinical atherosclerosis. 
Lifestyle modifications represent the cornerstone of weight management in youth; 
however, very few successful pediatric obesity treatments are currently available 
(Whitlock et al., 2010), and only a small number include measures of subclinical 
atherosclerosis as endpoints (Fernhall & Agiovlasitis, 2008). Most interventions that 
focus on improving cardiovascular health in obese youth evaluate traditional CVD risk 
factors. Even in adults, traditional CVD risk factors do not fully explain cardiovascular 
health,(Naghavi et al., 2003) and evidence suggests that postprandial dysregulation may 
be a better predictor of future cardiovascular events (Bansal et al., 2007). The 
postprandial state may be more reflective of a physiological regulation and dysregulation, 
as  most individuals eat throughout the day. Therefore, it is critical to examine if and how 
interventions impact cardiovascular health during the critical postprandial period. Given 
the potential prognostic value of endothelial function on cardiovascular events in 
adults(Vita & Keaney, 2002), the degree to which acute perturbations are associated with 
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endothelial dysfunction across different populations of youth is of interest. Moreover, the 
ability of exercise to attenuate postprandial endothelial dysfunction has important 
implications for developing future CVD prevention programs in high-risk youth. This 
dissertation addresses one of the most significant public health problems facing our 
society in terms of the numbers of youth impacted by obesity and the current and future 
healthcare costs of the target population. The approach is significant in that we employed 
direct measures of cardiovascular health under physiologically meaningful conditions 
using a clinically relevant translational design. The overall goal of this study was to 
examine the potential for high-intensity exercise to improve postprandial endothelial 
function in obese youth. 
Specific Aims and Hypotheses 
Aim #1: To determine the effect of high-intensity interval exercise on fasting and 
postprandial endothelial function in obese (BMI-percentile ≥97th) adolescents. 
Hypothesis #1.1: A single bout of exercise prior to consumption of a high-fat meal will 
protect against postprandial endothelial dysfunction as measured by sustained brachial 
artery flow mediated dilation. 
Hypothesis #1.2: A single bout of exercise will improve fasting endothelial function. 
Delimitations 
The delimitations for this study include: Males who are between the ages of 13 
and 17. They must possess a BMI ≥97th percentile for their given age. They must be non-
smokers with no history of Type 1 or Type 2 diabetes and no current medication use. In 
addition, since the study required exercise, participants must have no physical 
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impairments that might limit exercise ability (e.g. Asthma, orthopedic limitations etc.). 
Also, participants must not meet the current evidence based guidelines for physical 
activity for youth (<60min/day). 
Limitation 
There may be alternative approaches to examining how exercise improves CVD risk in 
youth. The challenge with assessing cardiovascular health in younger populations is that 
no one measure best predicts future risk. Several risk factors/biomarkers of CVD have 
been proposed in youth (Balagopal et al., 2011; Kavey et al., 2006), but we opted to 
assess a proximal indicator of vascular health that is one of the earliest manifestations of 
the atherosclerotic process (Verma, Buchanan, & Anderson, 2003). It is acknowledged 
that structural measures (e.g. carotid intimal medial thickness) are also important early 
indicators of subclinical atherosclerosis in youth (Urbina et al., 2009), but structural 
measures may require long-term investigation and may not be sensitive to acute 
perturbations in diet and exercise. The nature of our design was to establish the feasibility 
of high-intensity exercise to improve endothelial function in a postprandial period in the 
hopes of translating this evidence into future interventions for high-risk youth. However, 
due to the nature of the study, exclusion of female participants was necessary in this 
proof of concept design, as female participants require specific controls due to menstrual 
cycle, which can influence results (Thijssen et al., 2011). Additionally, the lack of ability 
to measure tanner stage is a limitation, but given the nature of the investigation, we feel 
that this does not limit our ability to determine the success of our aims. While alternative 
exercise strategies were considered, this novel and innovative exercise dosage deserves 
further attention for its cardioprotective properties.  
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CHAPTER 4: STUDY DESIGN AND METHODS 
Study Design 
A randomized, cross-over design by condition was used for the following study. 
The Arizona State University Institutional Review Board approved the study, and all 
participants as well as a parent/guardian provided written informed consent prior to 
enrollment.  
Recruitment 
We enrolled a total of 14 obese (BMI-percentile 98.5 ± 0.6) male adolescents 
between the ages of 13-16 (14.3±1.0 years). Participants were recruited via a variety of 
efforts including flyers (Appendix H and I), newspaper ads, approved social media,  re-
contacting previous study participants, and word-of-mouth. Recruitment efforts were 
facilitated in both English and Spanish.  
Participant Screening 
 After subjects were identified via recruitment efforts (Appendix P for recruitment 
consort), they were screened using a standard in-person or telephone screening process in 
their preferred language (either English or Spanish) by using a standardized screening 
form (Appendix B). If potential participants met all inclusion criteria, they were invited 
to come to the ASU Healthy Lifestyle Research Center (HLRC) for a screening visit. For 
this visit, they were asked to be fasted; however, it was not a requirement of the visit. If 
they were not fasted, consent and assent were received, anthropometrics were taken, and 
an additional fasting visit was scheduled.  
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Rolling Enrollment 
 Participants were enrolled after successful completion of initial phone screening. 
Enrollment began on June 2013 and was concluded on January 2014. A detailed 
description of enrollment based on screening are provided in Appendix P. 
Eligibility 
The inclusion and exclusion criteria for the present study are located in Appendix A. We 
recruited individuals who did not meet the current evidence-based guidelines for physical 
activity for youth (<60min/day) (W. B. Strong et al., 2005), as prior/current exercise 
training my elicit different responses due to arterial remodeling (D. J. Green, 2009). 
Participants must have been males aged 13-17 with a BMI percentile ≥97th who had  no 
exercise limitations. Participants were excluded if they had type 1 or type 2 diabetes. If 
participants were taking medication, vitamin C, or a multi-vitamin, they were excluded. 
During the screening visit, we excluded participants who we are unable to achieve a 
useable FMD image due to poor acoustic window of the ultrasound procedure. During the 
phone screening, we excluded participants who identified as lactose intolerant, and if they 
experienced meal intolerance (i.e. diarrhea), they were either excluded from the study or 
asked to re-do the visit in which they experienced the issue.  
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Randomization 
A simple block-randomization was used for sequence of meal challenge visits wherein  
50% of participants received the Exercise plus Meal (Ex+M) condition prior to the (meal 
only) MO condition and the other 50% received the MO condition prior to the Ex+M 
condition. This was done to control for any possible sequencing effect and was examined 
in data analysis.  
 
 
 
 
 
 
Sample Size 
Sample size was based upon a previously conducted power analysis using 
preliminary data on lean youth (Appendix L) to test change in screening FMD versus 4hr 
FMD across the 2 conditions (MO and Ex+M). The effect size (f) used for the analysis 
was 0.25, which was estimated using the preliminary data for this analysis using partial 
η2 for a condition x time interaction. Utilizing an α = 0.05 at a power (1-β) = 0.80 for 2 
groups with 2 measurements and a correlation between repeated measures of r = 0.60, we 
required a sample size of n=14 to achieve statistical significance.  
Screening 
Visit 
Randomize 
(72hr washout) 
Meal Only 
Condition 
Exercise + Meal 
Condition 
Meal Only 
Condition 
72hr washout 
Exercise + Meal 
Condition 
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Methods 
Eligible participants were invited to come to the HLRC for 4 visits detailed 
below, and a 100% retention rate was achieved.  
Screening Visit   
Participants arrived at the HLRC at ~09:00 after an overnight fast (>10 hrs). After 
assent and consent were obtained, a brief physical exam was performed to assess height 
and weight. Body weight was used to determine the meal composition given, in which 
0.7g of fat was given per kg of body weight. Supine blood pressure was measured in 
triplicate using an appropriately-sized cuff on the left arm after the subject has rested 
quietly for at least 15 min. This was done in order to determine the necessary pressure 
needed of the cuff during the occlusion period for the FMD procedure. Participants had 
an assessment of their brachial artery FMD tested for baseline measure and as a screening 
criterion using previously established methodology (Harris et al., 2010; Thijssen et al., 
2011). Cardiorespiratory fitness (VO2peak) was determined using a mechanically braked 
cycle ergometer and an integrated metabolic system (ParvoMedics TrueOne 2400). 
Participants were oriented to the testing equipment and cycling cadence (50-70 RPMs) 
prior to test initiation. The McMaster protocol was used to determine VO2peak, as it 
allows for height-specific workload adjustments in order to provide steady-state exercise 
increases in a linear fashion. VO2peak was based upon subjective (participant exhaustion 
despite verbal encouragement) and objective (RER > 1.0) criteria and defined as the 
highest 15-second oxygen average consumption achieved. Work rates in relation to 
oxygen consumption and heart rate (HR) were recorded throughout the test and 
46 
 
subsequently used to determine workloads for the exercise bout. At the conclusion of the 
VO2peak test, participants were given a snack. Upon successful completion of the 
screening visit, participants were randomized to either the Ex+M→M sequence or 
M→Ex+M sequence. A minimum washout period of 72hr after any exercise visit was 
required in order to minimize the effect of exercise on endothelial adaptation. This time-
course was selected based on the available time-course literature on high-intensity 
exercise on endothelial function.(Haram et al., 2006)  Regardless of sequence 
randomization, study procedures were identical. Table 2 gives a detailed description of 
the order and measures taken on each visit. A detailed study design and timeline chart is 
presented in Appendix C. 
Exercise Visit (sequence Ex+M) 
Participants returned to the HLRC at ~17:00 to complete an exercise session. A 
single bout of high-intensity interval exercise was performed on a cycle ergometer based 
upon baseline fitness levels obtained during the screening visit. The exercise bout 
included a 5-min warm-up period (50% of peak HR) followed by 8-intervals of 2-min at 
>90% peak HR and 2-min of active recovery (~50% of peak HR) between each high-
intensity period. After completion of the 8-intervals, a 5-min cool down period of 
unloaded pedaling was performed, for a total of 42-min of exercise. This exercise 
stimulus was selected based on research in adults, (Tyldum et al., 2009) and a similar 
exercise dose has been used in obese youth to improve cardiac function (Ingul et al., 
2010). Participants were instructed to refrain from further exercise and caffeinated 
beverages and were provided a standardized meal which was consumed prior to 22:00.  
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Meal Visits (regardless of sequence) 
Participants returned to the HLRC at ~9:00 for assessment of fasting endothelial 
function measured by brachial artery FMD. Participants rested quietly in the supine 
position in a dim, climate controlled room for at least 20-min prior to FMD assessment. 
Following baseline FMD measurement, a standardized high-fat meal in milk-shake form 
was given. The meal was a mixture of~65% fat, ~5% protein, and ~30% carbohydrate,  
and was consumed at a slow pace in full within 15 min (Table 4 and Appendix M). The 
fat content of the meal was based upon body weight with a ratio of 0.7g/kg of weight 
given. This meal was selected for the high level of control, and similar fat loads and meal 
compositions have been shown to significantly impair endothelial function in healthy 
adults (Gosmanov, Smiley, Robalino, Siquiera, et al., 2010). Our pilot data suggest that a 
similar meal composition (a standard meal of 50g Fat, 63g CHO, and 36g Protein) is 
associated with endothelial dysfunction in lean and overweight adolescents. Following 
the meal, participants remained seated or lying down, and FMD was reassessed at 2-hr, 
and 4-hr post consumption. Participants were provided a standardized dinner (subway 
dinner, Appendix N) and instructed to refrain from any structured exercise and 
caffeinated beverages for 24-hr. 
Brachial Artery Flow-mediated Dilatation 
Images of the brachial artery were obtained using high-resolution 2D and Doppler 
ultrasound (Terason t3000CV ultrasound, Terason Ultrasound, Burlington, MA) with a 
linear-array transducer at a transmit frequency of 12 MHz. Imaging was performed 
following 20-min of supine rest on participants’ left arm which was immobilized in an 
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extended position (80° abduction). Images of the brachial artery were obtained in the 
longitudinal plane, proximal to the antecubital fold. The ultrasound procedure was 
individualized to optimize image clarity and to avoid areas of arterial branching. Probe 
location was marked during the first measurement of each test day and repeat 
measurements performed in the same region. In addition, anatomical landmarks visible 
on ultrasound were used to ensure proper location of the probe between trials. Following 
image optimization (and before cuff inflation), digital video of the procedure was 
captured for 1-min to determine average brachial artery diameter. A blood pressure cuff 
(placed 2 cm distal to the antecubital fold) was inflated to >200mmHg (or greater than 
50mmHg above systolic) for 5-min. Digital video was recorded for 1-min prior to cuff 
releases and upon cuff release for at least 3-min in order to assess peak blood flow and 
determine peak dilation. Digital video was analyzed with semi-automated edge-detection 
software (Woodman et al., 2001) by a single investigator who was randomized and 
blinded to conditions. All images were analyzed in duplicate with mean values 
taken. Arterial diameters were calculated as the mean distance between the anterior and 
posterior wall at the intima-lumen interface. FMD was defined as the change in vessel 
diameter from rest to peak dilation as a percentage of the baseline diameter. Peak shear 
rate was calculated as the peak hyperemic velocity divided by the baseline vessel 
diameter (Pyke & Tschakovsky, 2005). We have standardized the procedures within our 
lab (Appendix K) and have shown good intra- and inter-user reliability (Appendix O). 
Data Analysis 
To test hypothesis 1.1, we used a repeated measures ANOVA to analyze the 
magnitude of change in FMD from screening to 4 hour FMD by condition. Additionally, 
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adjusted  for shear stress and baseline artery diameter for each measure in order to reduce 
confounding. Adjusting for shear stress and baseline artery diameter was necessary, as 
they are known to influence FMD and may be influenced by the meal and/or exercise 
(Thijssen et al., 2011). Hypothesis 1.2 was evaluated in the same statistical analysis 
substituting baseline fasting FMD as the measure of interest. These analytical procedures 
are similar to those used in similarly designed postprandial endothelial function studies 
(Tyldum et al., 2009). 
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CHAPTER 5: RESULTS 
Baseline Characteristics  
Fourteen obese male adolescents completed all study visits and were used for subsequent 
analysis. Of the 14 participants, 9 were classified as being severely obese, with their 
BMI-percentile exceeding 120% of the 95%tile for age and gender.(Aaron S. Kelly et al., 
2013) Based upon screening blood pressure, which was taken while supine, we observed 
that 4 participants exhibited pre-hypertension and 1 participant was classified as 
hypertensive. Table 1 shows the sample demographic, anthropometric, and blood 
pressure characteristics taken during the screening visit.    
 
 
 
 
Table 1. Sample characteristics of adolescents who completed the study.
n =14 Mean ± SD Range
Age 14.3 ± 1.0 13 - 16
Height (cm) 170.1 ± 8.2 156.5 - 185.0
Weight (kg) 92.6 ± 10.2 77.5 - 111.1
BMI (kg/m2) 31.9 ± 1.8 28.5 - 34.5
BMI-percentile (%) 98.5 ± 0.6 97.0 - 99.2
Obesity Status
SBP (mmHg) 119 ± 7 106 - 133
DBP (mmHg) 65 ± 8 43 - 77
Resting HR (bpm) 68 ± 8 58 - 85
Hypertension status Hypertensive (n=1), Pre-hypertension (n=4)
All data are mean ± SD
Severely Obese (n =9)
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Table 2. Detailed description of each visit.
Screening
Arrive 09:00 fasted
Consent/Assent
Anthropometrics
Lay down in dark quiet room 20min
Blood pressure (Triplicate)
Flow-Mediated Dilation
VO2peak test
Randomization
 (Meal only or Exercise + Meal)
Exercise Visit
Arrive 17:00 
5 min warm-up
8 x 2min ≥90% Hrmax
2min active recovery
5 min cool-down
Subway dinner prior to 22:00
Meal Visit
Arrive 09:00 fasted
Lay down in dark quiet room 20min
Blood pressure (Triplicate)
Flow-Mediated Dilation
Milkshake consumed (65% FAT, 30% CHO, 5% PRO)
Flow-Mediated Dilation (2 hours post-meal)
Flow-Mediated Dilation (4 hours post-meal)
Table 2 gives a details description and order of methods taken during each visit. Each 
participant completed the Meal visit on 2 different occasions. One occasion was preceded 
by an exercise visit while another visit was preceded by no exercise. For further 
reference, a detailed study design and timeline chart appears in Appendix C. 
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Table 3 displays the exercise testing results from the VO2peak test. The VO2peak test was 
used in order to determine an exercise prescription which consisted of 8 X 2min bouts at 
90%HRmax and 2 min active recovery between bouts at 50% HRmax. All participants 
completed all 8 bouts of exercise which was preceded by a 5min warm-up and followed 
by a 5min cool-down. On average >6 of the bouts were completed at 90%HRmax. 
 
Table 4 shows the meal composition breakdown for the cohort. Each meal was tailored to 
the body weight of each participant with a fat load of 0.7g of fat given per kg of 
bodyweight.  
 
 
 
 
Mean ± SD Range
VO2peak (ml/kg/min) 27.7 ± 4.9 20.8 - 36.4
VO2peak (L/min) 2.6 ± 0.5 1.8 - 3.3
HRmax (bpm) 195 ± 6 186 - 207
RERpeak 1.06 ± 0.04 0.98 - 1.15
Plateau in VO2
Peak watts 170 ± 32 121 - 221
50% HRmax (bpm) 97 ± 3 92 - 103
90% HRmax (bpm) 175 ± 6 165 - 185
50% work load (watts) 43 ± 7 30 - 50
90% work load (watts)  141 ± 28 102 - 190
Number of bouts completed
Number of bouts completed at ≥90% HRmax 6.2 ± 0.8 `5 - 8
All data are mean ± SD
4 participants
All bouts completed by each participant
Table 3. Exercise testing and exercise prescription characteristics.
Table 4. Weight of participants and meal  characteristics.
Mean ± SD Range
Weight (kg)
#
92.6 ± 10.2 77.5 - 111.1
Fat load (g) 64.9 ± 7.0 54.6 - 77.7
Total (kcal) 889 ± 95 746 - 1065
Fat (kcal) ~65% 583 ± 62 489 - 699
CHO (kcal) ~30% 264 ± 28 222 - 316
Protein (kcal) ~5% 45 ± 5 37 - 53
All data are mean ± SD
#
Fat load used is based upon body weight of each 
participant, 0.7g of fat per kg of body weight
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Main Outcomes 
Aim #1: To determine the effect of high-intensity interval exercise on fasting and 
postprandial endothelial function in obese (BMI-percentile ≥97th) adolescents. 
Hypothesis #1.1: A single bout of exercise prior to consumption of a high-fat meal will 
protect against postprandial endothelial dysfunction as measured by sustained brachial 
artery flow mediated dilation. 
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We observed that despite consumption of a high-fat meal there was no decrement in FMD at 
2hr or 4hr post-meal in either condition. No significant differences were observed between 
the exercise + meal condition and the meal only condition.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effect of high-intensity interval exercise on postprandial endothelial function in obese 
adolescent males. Data are presented as means ± SE. Ex+M = Exercise prior to the meal 
condition; MO = Meal only condition without prior exercise.  
Table 5. Effect of exercise on postprandial endothelial function.
FMD% 95% CI FMD% 95% CI
Screening 7.0 ± 3.0 5.2 - 8.8 7.0 ± 3.0 5.2 - 8.8
Fasting 7.5 ± 3.0 5.7 - 9.3 7.4 ± 2.8 5.6 - 9.2
2 hour 8.4 ± 3.4 6.5 - 10.2 7.6 ± 3.9 5.8 - 9.4
4 hour 8.8 ± 3.9 7.0 - 10.7 8.6 ± 4.0 6.7 - 10.4
p-value
Linear Mixed Model 0.667
0.277
0.974
Data are mean ± SD
Exercise + Meal Meal Only
Condition
Time
Condition * Time
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Table 6. Effect of exercise on postprandial endothelial function, without screening.
FMD% 95% CI FMD% 95% CI
Fasting 7.5 ± 3.0 5.7 - 9.3 7.4 ± 2.8 5.6 - 9.2
2 hour 8.4 ± 3.4 6.5 - 10.2 7.6 ± 3.9 5.8 - 9.4
4 hour 8.8 ± 3.9 7.0 - 10.7 8.6 ± 4.0 6.7 - 10.4
p-value
Linear Mixed Model 0.632
0.418
0.928
Data are mean ± SD
Exercise + Meal Meal Only
Condition
Time
Condition * Time
Upon removal of the screening visit from the analysis we observed no difference between groups. 
While FMD appears to improve over time, we observed no significant time effect of the meal. 
Suggesting, the meal was unable to induce endothelial dysfunction. 
 
 
Figure 2. Effect of high-intensity interval exercise on postprandial endothelial function in 
obese adolescent males, without screening visit. Data are presented as means ± SE. 
Ex+M = Exercise prior to the meal condition; MO = Meal only condition without prior 
exercise.  
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Hypothesis #1.2: A single bout of exercise will improve fasting endothelial function. 
We observed no improvement in fasting endothelial function the morning after high-
intensity exercise. We observed no difference between fasting and screening endothelial 
function in either condition. 
 
 
Figure 3. Effect of high-intensity interval exercise on fasting endothelial function in 
obese adolescent males. Data are presented as means ± SE. Ex+M = Exercise prior to the 
meal condition; MO = Meal only condition without prior exercise.  
Table 7. Effect of exercise on fasting endothelial function.
FMD% 95% CI FMD% 95% CI
Screening 7.0 ± 3.0 5.2 - 8.8 7.0 ± 3.0 5.2 - 8.8
Fasting 7.5 ± 3.0 5.7 - 9.3 7.4 ± 2.8 5.6 - 9.2
p-value
RM ANOVA 0.965
0.329
0.927
Data are mean ± SD
Condition * Time
Exercise + Meal Meal Only
Condition
Time
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Other Outcomes Measures and Exploratory Hypothesis 
When examining the only the exercise plus meal condition, we observed a significant 
reduction in time to peak vasodilation after exercise in the fasting condition compared 
with 2 hours (p=0.02) and a trend at 4 hours (p=0.08). We observed no difference in the 
meal only condition and when groups were compared we found no differences.  
 
 
Figure 4. Effect of high-intensity interval exercise on time to peak vasodilation in obese 
adolescent males. Data are presented as means ± SE. Ex+M = Exercise prior to the meal 
condition; MO = Meal only condition without prior exercise.  
Table 8. Effect of exercise on time to peak vasodilation.
Fasting (sec)
2 hour (sec)
4 hour (sec)
p-value
Linear Mixed Model 0.45
0.66
0.541
Data are mean ± SD
* p = 0.02 (paired t-test vs. fasting)
#
 p = 0.08 (paired t-test vs. fasting)
Condition
Time
Condition * Time
77.5 ± 19.9
#
80.0 ± 19.6 
79.0 ± 21.5
78.9  ± 21.5
80.5  ± 18.6*
Exercise + Meal Meal Only
Time to peakTime to Peak
69.8 ± 19.8
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Despite the consumption of a high-fat meal we observed no change in shear rate (Table 
9) in either condition. Despite this there remains a modest, significant relationship 
between shear rate and FMD and will be adjusted for in further analysis.  
 
 
 
 
 
 
 
 
 
 
Figure 5. Effect of high-intensity interval exercise on average shear rate in obese 
adolescent males. Data are presented as means ± SE. Ex+M = Exercise prior to the meal 
condition; MO = Meal only condition without prior exercise.  
Table 9. Effect of exercise on average shear rate.
Fasting (1/sec)
2 hour (1/sec)
4 hour (1/sec)
p-value
Linear Mixed Model 0.694
0.638
0.965
Data are mean ± SD
Condition * Time
326.6  ± 119 325 ± 102
348 ± 98 332 ± 75
Condition
Time
Average Shear Rate Average Shear Rate
Exercise + Meal Meal Only
355 ± 100 346 ± 118
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Figure 6. Relationship between pre-occlusion and occlusion baseline diameters split by 
condition.  
Screening: Pre-occlusion Occulsion Peak
Pre-occlusion - 0.992 0.948
Occulsion 0.992 - 0.975
Peak 0.948 0.975 -
Fasting 
Pre-occlusion - 0.932 0.941
Occulsion 0.932 - 0.975
Peak 0.941 0.975 -
2 Hour
Pre-occlusion - 0.980 0.967
Occulsion 0.980 - 0.974
Peak 0.967 0.974 -
4 Hour
Pre-occlusion - 0.965 0.947
Occulsion 0.965 - 0.962
Peak 0.947 0.962 -
All correlations are p<0.001
Table 10. Pearson correlations of baseline (pre-occlusion and 
during-occulsion) and peak diameters by condtion.
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Figure 7. Relationship between peak diameter and occlusion baseline diameters split by 
condition.  
 
 
 
 
 
 
 
 
.  
 
 
Figure 8. Relationship between FMD% and occlusion baseline diameters split by 
condition. Over the entire sample there was a significant correlation between FMD and 
baseline diameter (r = -0.45, p<0.001). 
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Figure 9. Relationship between FMD% and shear rate split by condition. Over the entire 
sample there was a significant correlation between FMD and shear rate (r = 0.40, 
p<0.001). 
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FMD% 95% CI FMD% 95% CI
Fasting 7.7 ± 3.0 6.0 - 9.3 7.4 ± 2.8 5.8 - 9.0
2 hour 8.4 ± 3.4 6.8 - 10.1 7.5 ± 3.9 5.8 - 9.1
4 hour 8.9 ± 3.9 7.3 - 10.5 8.5 ± 4.0 7.0 - 10.1
p-value
Linear Mixed Model 0.417
0.342
0.891
<0.001
0.106
Data are mean ± SD
Baseline Diameter
Shear Rate
Table 11. Effect of exercise on postprandial endothelial function adjusted 
for baseline diameter and shear rate.
Exercise + Meal Meal Only
Condition
Time
Condition * Time
 
Figures 8 and 9, show a significant relationship between FMD and baseline diameter and 
shear rate, respectively.  After adjusting for baseline diameter and shear rate, we observed 
no difference between the two conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Effect of high-intensity interval exercise on postprandial endothelial function 
in obese adolescent males, adjusted for baseline diameter and shear rate. Data are 
presented as means ± SE. Ex+M = Exercise prior to the meal condition; MO = Meal only 
condition without prior exercise. 
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Data were split at the median by baseline levels (screening visit) of endothelial function.  
Those whose FMD was >7.6% were classified as good function while those <7.6% were 
classified as having endothelial dysfunction.  Date were analyzed as separate groups 
adjusting for baseline diameter and shear rate, showing no endothelial dysfunction due to 
the meal in either group. 
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CHAPTER 6: DISCUSSION 
Discussion 
 The present study investigated the effect of high-intensity interval exercise on 
postprandial endothelial function in obese male adolescents. We observed that high-
intensity interval exercise, the evening prior, had no effect on fasting endothelial function 
and did not improve postprandial endothelial function when compared with a meal only 
condition. Despite consuming a high-fat meal, endothelial function in the meal only 
condition did not decline from fasting levels.  Although with exercise endothelial 
function increased at 2 hours and 4 hours post-meal, the effect size was not substantial 
enough to show an improvement over a condition with no prior exercise.   
We designed the present study based upon pilot data which suggested that 
exercise protected against postprandial endothelial dysfunction in lean male adolescents 
(Appendix L). Due to our pilot study experience, we implemented several designs as well 
as methodological changes which were aimed at reducing variability observed into the 
present investigation. Unlike our pilot study, we used a meal that was tailored to each 
participant instead of a fixed-dose. This allowed for an individualized approach, which 
we felt was more rigorous than a fixed-meal challenge. In order to reduce variability due 
to food consumed within the testing period, we gave participants standardized meals the 
night prior as an added measure of control. Although our pilot study was conducted in 
lean youth, we chose to examine a high-risk obese population, as the translational 
potential to use exercise as a prescription may be more readily applied in this population. 
We made rigorous attempts to standardize and refine our FMD procedures and protocol 
on both the assessment and the analysis end. Participants were only allowed to read, do 
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homework, or sleep during the 5 hour FMD test period, as we wanted to exclude any 
behaviors which might have influence on endothelial function. We demonstrated good 
inter-user and intra-observer reliability of our FMD analysis procedure. However, despite 
these controls and methodological refinements, we were unable to demonstrate that 
exercise was able to protect against postprandial endothelial dysfunction. Furthermore, 
large inter-individual difference still remained within our data, which makes 
interpretation of our findings challenging. Despite these outcomes, there are several 
possible explanations for our results. 
Dose of Exercise and Mode  
 We utilized a high-intensity interval exercise bout that had been previously shown 
to improve postprandial endothelial function in sedentary overweight men. (Tyldum et 
al., 2009) The exercise protocols were very similar we used a 8 X 2min bout with 2min 
of active recovery, in contrast Tyldum et al. used a 4 x 4min bout with 3min of active 
recovery. The total amount of time spent in the high-intensity phase was the same, and 
the exercise was well tolerated by the youth in our study. It is possible that a single acute 
bout of exercise may not be sufficient to improve endothelial function at fasting or during 
a postprandial period in obese adolescent males. There is substantial evidence to support 
the efficacy of exercise training on vascular adaptation.(D. Green, 2009) Furthermore, 
exercise training has been shown to be effective at improving fasting endothelial function 
in overweight/obese adolescents.(Kelly et al., 2004) Future research should examine 
whether exercise training may be able to protect against postprandial endothelial 
dysfunction in obese adolescents. 
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The modality of exercise used in our study differed from other successful 
postprandial endothelial function studies. Our bout of exercise was completed on a cycle 
ergometer, whereas the Tyldum et al. used a treadmill. Various modes of exercise 
produce different patterns of arterial shear, and differing shear patterns result in distinct 
responses in vascular function (D. Green et al., 2005; Thijssen et al., 2009). While 
treadmill and cycling exercise exhibit similar effects on shear rate and shear pattern in 
lower extremities, what may be lacking is the upper limb movement and shear pattern to 
stimulate NO bioavailability in the brachial artery. Perhaps, more importantly, the 
magnitude of changes observed in shear rate during walking appears at a much lower 
heart rate intensity than during cycling exercise.(Thijssen et al., 2009) Therefore, in 
exercise that uses a prescription based upon HR, the shear rate during treadmill exercise 
would surpass that of cycling at the same HR value. Coupled with the effects of upper 
body movement and larger amounts of muscle mass used for the exercise, treadmill 
exercise may be a more optimal exercise mode for acute exercise studies. However, this 
effect could be localized to different artery sections. Therefore, future research should 
examine the effect that cycling exercise has on femoral flow-mediated dilation in order 
better determine the effect of cycling on this more localized artery. Additionally, a 
comparison of the same high-intensity interval exercise protocols on different modalities 
would be able to answer the questions posed.  
This hypothesis, that treadmill walking may be superior to cycling for acute 
improvement in postprandial endothelial function, is supported by two studies in youth, 
which have been successful at inducing endothelial dysfunction and showing a protective 
67 
 
effect of exercise (MJ Sedgwick et al., 2013; MJ. Sedgwick et al., 2014). Each study 
provided youth with 2 meals (breakfast and lunch) and measured FMD at fasting, 3 
hours, and 6 hours after consumption of the first meal. The exercise for one study 
occurred in the evening and consisted of four 15 min walking periods at 60% of 
VO2peak, which included 3 min of rest between bouts. The other investigation split 
60min of exercise into 6 x 10 min of bouts throughout the day with 50min of rest 
between each bout. Each 10min bout was at 70% of VO2peak on a treadmill. In both 
studies, they observed no difference in FMD at fasting; however, at 3 hours and 6.5 hours 
post-meal, the exercise was able to protect against postprandial endothelial dysfunction 
observed in the meal only condition (p<0.001). Thus, when combined with the findings 
from Tyldum and colleagues, perhaps, the exercise modality is a potential explanation for 
our findings. 
Meal Dose and Composition 
We observed that despite consuming a high-fat meal, the obese adolescent males 
did not exhibit endothelial dysfunction in either condition. While our meal was tailored to 
each individual with a fat load of 0.7g/kg of body weight given, this “dose” may not have 
been enough to induce endothelial function consistently in this population. The studies by 
Sedgwich et al. (MJ Sedgwick et al., 2013; MJ. Sedgwick et al., 2014)  were able to 
induce endothelial dysfunction at 3hrs with an initial meal challenge of 22.2 kcal/ kg 
body weight to lean youth. While our meal dose was greater overall, we were only 
providing 9.6kcal/kg body weight. However, if we provided the same meal dose used by 
Sedgwich and colleagues our participants, on average, would have consumed ~2055kcal, 
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which may not be practical or “real world”. The study by Tyldum et al.(Tyldum et al., 
2009) that provided a fixed meal which was 10.1 kcal/kg of body weight, much similar to 
ours, suggested that this may be a function of obese youth requiring a greater dose than 
healthy overweight adults in order to induce endothelial dysfunction. Additionally, our 
study is not the first to show that a high-fat meal does not induce postprandial endothelial 
dysfunction. Ayers et al. gave 7 healthy normal weight and 7 healthy obese young adults 
(32±6 yr) a standardized high-fat meal consisting of 60g of fat and 1000kcal (Ayer et al., 
2010). Despite consuming the high-fat meal, they observed no change in FMD from 
baseline to 3hr post-meal in either the normal-weight (4.7±4.1 to 4.3±3.9%) or obese 
group (6.2±1.7 to 5.8±4.3%, p(group*time) = 0.975). Future studies may want to examine the 
dose response relationship with different tailored high-fat meals in obese youth in order 
to determine the optimal load of fat or kcal to provide.   
Another potential explanation for why we did not observe postprandial 
endothelial dysfunction in our study is due to the nature of the response to the mixed-
meal. Raitakari and colleagues examined the effect of two high-fat meals (1030kcal, 61g 
fat) consisting of differing fatty acid compositions in 12 normal-weight/overweight men 
and women (33±7yr, BMI = 24.3±3.1 kg/m
2
).(Raitakari et al., 2000) They observed no 
change in FMD at 3 hours or 6 hours post-meal in either meal.  However, they observed 
that, with either meal, participants had increased forearm blood flow, increased 
triglycerides, and increased insulin at 3 hours in response to the meal. The increase in 
forearm blood flow was highly associated with the insulin response observed (r = 0.80, 
p<0.002). The authors suggest that the hyperinsulinemia response observed in the 
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postprandial state mediated changes in forearm blood flow, which may counteract any 
detrimental effects of that meal on endothelial function.  
While it is documented that oral and intravenous fat challenges produce 
postprandial endothelial dysfunction,(Gosmanov, Smiley, Robalino, Siquiera, et al., 
2010) the results from mixed meal challenges are not as conclusive.(Jackson et al., 2007)  
This could potentially be due to the insulin response post-meal, as insulin is a potent 
vasodilator. In healthy persons insulin via its action on the insulin receptor on the 
endothelial cell surface stimulates a cascade of molecular signals through a PI3-k 
pathway to phosphorylate eNOS and stimulates the production of NO to increase 
vasodilatitory capacity.(Muniyappa et al., 2007). Thus, it is possible that compensatory 
hyperinsulinemia enhanced NO bioavailability in our study, which could explain the lack 
of postprandial endothelial dysfunction with the meal observed. This hypothesis is only 
supported, however, if the endothelium is insulin sensitive, as an insulin resistant 
endothelial cell favors a MAP-k pathway which produces higher amounts endothelin-1, a 
potent vasoconstrictor. Future studies should determine if the degree of insulin response 
during a mixed-meal is the mechanism mediating the lack of postprandial endothelial 
dysfunction that has been observed.  
Population 
The present investigation is the first to examine the effects of a mixed-meal in 
obese adolescents. However, a study by Metzig and colleagues examined the effects of a 
glucose tolerance challenge on postprandial endothelial function in obese adolescents and 
found no endothelial dysfunction due to the glucose load.(Metzig et al., 2011) While the 
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evidence in favor of a high-fat meal inducing endothelial dysfunction is greater, this 
highlights the possibility that these young persons, despite being obese, may be protected 
against any vascular compromise, at least at this stage of the lifecycle.   
The lack of arterial aging may have contributed to our findings on postprandial 
endothelial function. Middle aged and older adults experience losses in arterial 
compliance, forearm blood flow, and endothelial function over-time. Furthermore, these 
losses are compounded by a lack of physical activity, but they can be restored with 
exercise training.(DeSouza et al., 2000) However, young individuals appear to be 
resistant to reductions in arterial compliance and endothelial function, despite a lack 
physical activity or low fitness levels.(Seals, Walker, Pierce, & Lesniewski, 2009) Our 
fasting endothelial function values are consistent with those reported in the literature for 
obese youth, but there is no data for comparison during a mixed-meal post-absorptive 
state.(Charakida et al., 2012; Naylor et al., 2011) However, it should be noted that the 
arterial aging argument only applies to the fasting state, as not data are presently 
available on the effects of aging on postprandial endothelial function which needs to be 
investigated. Therefore, despite our sample being sedentary and relatively low fit, they 
may be protected against reduced endothelial function due to a lack of senescence.   
We designed this study on the premise that physically inactive individuals may 
exhibit greater endothelial dysfunction and are more prone to improvements in 
postprandial endothelial function with exercise. Johnson and colleagues examined the 
effects of a high-fat meal on postprandial endothelial function in physically inactive and 
active normal-weight, healthy young adults. FMD was measured at fasting and 4hrs post-
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meal (940kcal, 46%fat). They observed that while the active individuals were protected 
against endothelial dysfunction at 4hrs post-meal, the inactive persons exhibited 
significant endothelial dysfunction (p=0.02).(Johnson et al., 2011) While, physical 
inactivity may play a role in adults, the present study recruited physically inactive 
persons; thus, this may not be the operation in youth. Furthermore, physical fitness 
(VO2peak) was not associated with FMD at screening or during the postprandial period at 
any time point in the present study. More data is needed on the relationship between 
fitness and endothelial function in youth. However, the present investigation suggests that 
while the importance of physical activity and fitness is undisputed, it may not play a role 
on fasting or postprandial endothelial function in obese youth.    
Additionally, there were several factors that we did not or were unable to control 
for in our study, which may have impacted our findings. We did not account for exposure 
to smoking at the individual or familial/second hand level, exposure to smoke is 
documented to be associated with endothelial dysfunction.(D S Celermajer et al., 1993) 
We selected an age range of youth that are undergoing pubertal maturation which may 
have contributed to the variability in our results. However, recent data suggests that 
despite pubertal difference on baseline vessel diameter and pubertal on-set insulin 
resistance, puberty appears to have little effect on endothelial function. (Marlatt et al., 
2013) We did not include females in this study; thus, our findings are only applicable to a 
single gender. The exclusion of females was necessary due to the proof of concept nature 
as well as the data suggesting that pre-menopausal women at all stages of the menstrual 
cycle may be inherently protected against postprandial endothelial dysfunction.(Harris, 
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Tedjasaputra, Zhao, & Richardson, 2012) Nevertheless, future studies should include 
females in order to determine if gender specific differences exist in youth.   
Overall Approach 
There are several features of our overall approach that may have contributed to our 
findings which are worthy of note. We used FMD as our primary outcome measure, as 
this had been previously shown to be a good measure of endothelial dysfunction during a 
postprandial state along as well as its sensitivity to acute perturbations such as exercise. 
We made many attempts to standardize and reduce the variability within the measure, but 
despite our best efforts, the reliability and reproducibility of our data must be questioned 
(Appendix Q). The two fasting conditions without prior exercise, screening FMD, and 
fasting MO FMD should have been very similar. We observed a mean difference between 
conditions of 0.48±2.52%; thus, while the mean difference was small, the large 
standardization is troubling. We observed only a modest correlation between the fasting 
endothelial function values (r = 0.554, P=0.040), and they were only modestly reliable 
(ICC= 0.712). Upon further regression analysis, we showed that only 30.7% (R
2
 = 0.307) 
of the variance in fasting FMD during the meal is explained by screening FMD, leaving 
69.3% of the variance due to other factors. This lack of consistency and sensitivity within 
same person, despite our best efforts, may have contributed to our findings.  
Perhaps, a biomarker of endothelial cell biology, which have been shown to be 
elevated in youth,(A. S. Kelly et al., 2010) may have been a better approach to answering 
the hypothesis posed.  Additionally, it is possible that a more robust imaging system such 
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as magnetic resonance imaging (MRI) could have been used, as its sensitivity is much 
higher than that of ultrasound.  
Currently, to our knowledge, there are no studies detailing the effects of diurnal 
variation or circadian variation on endothelial function or vascular tone in youth. Data in 
adults suggest that endothelial function is blunted in the early morning hours (6am) and 
rises towards mid-day (11am) where it is sustained throughout the day.(Otto et al., 2004)  
This may be due to higher vascular resistance in the morning hours coupled with lower 
blood flow, and as the day progresses, vascular resistance is reduced, which improves the 
ability of vasodilation to increase.(Panza, Epstein, & Quyyumi, 1991) However, diurnal 
increases in endothelial function have been observed in lean young adults but not in 
obese young adults (Hallmark et al., 2014), whether this is applicable in youth is 
unknown. While we did not have a no meal condition to study the effects of diurnal 
variation, it is plausible that the lack of reduction in endothelial function observed with 
the meal could be due to a counter effect of increases in diurnal variation. Future studies 
should include a control condition to examine diurnal variations effect on endothelial 
function.  
 
Strengths  
 Strengths of this study include the use of a standardized meal the night prior to 
meal challenge along with an individually tailored high-fat meal. The inclusion of 
individuals whose BMI percentile was > 97th and exclusion of physically active 
individuals allowed us to examine a targeted population of youth at highest-risk for 
premature CVD. We used a highly reproducible and translatable design by utilizing an 
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exercise prescription which would be easily implementable in any setting. We used a 
rigorous approach to FMD analysis by examining each file in duplicate, which is not 
common-place in the literature and allowed us to shown good consistency, 
reproducibility, and reliability of results.  
Limitations 
 While our study has many strengths, including a novel population and a readily 
translatable design, there are some limitations to note. The lack of inclusion of females 
did not allow us to access whether our findings were applicable to this gender. We were 
unable to measure blood samples (i.e. insulin, triglycerides, glucose, ect.), which may 
have given some additional insight into our findings and allowed us to examine potential 
mechanisms. The lack of inclusion of a control condition without a meal may have 
allowed us to determine if diurnal variation was the cause of some of the inter-individual 
variability and could have been beneficial. While we attempted to control for exercise 
and food the day prior, participants were free-living, which may have contributed to 
error.  We did not examine sleep quality or duration which may have impacted our 
findings and should be examined in subsequent investigations.  Our population was very 
heterogeneous and likely contributed to our biological variability.   
Future Research 
 Our findings need to be replicated in a population of youth with existing 
endothelial dysfunction, as this population may exhibit greater dysfunction with the meal.  
Further research is needed on the impact of various meal compositions and to determine 
if an inclusion of a no meal control day to examine diurnal variation is needed. Research 
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is needed on the dose-response relationship of fat load and degree of endothelial 
dysfunction which will aide in researchers’ ability to assume that a high-fat meal will 
induce endothelial dysfunction, as a lack of consistency is present within the literature. 
Future research should also examine the effect of exercise on other measures of 
endothelial function in a postprandial state.       
Potential Implications 
 Our findings may suggest that a high-fat meal may not induce endothelial 
dysfunction in obese and severely obese adolescent males.  While prior exercise may 
improve fasting endothelial function in lean youth, this may not be operational in obese 
male adolescents.  However, further research is needed in order to determine the optimal 
fat and caloric dose by which obese youth exhibit endothelial dysfunction, in order to 
better examine whether exercise can be protective.  
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APPENDIX A 
INCLUSION AND EXCLUSION CRITERION 
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Inclusion 
Age: 13-17 
Weight-status: BMI percentile >97th 
Male 
Less than 60 min/day of physical 
activity 
  
Exclusion 
Female 
Type 1 or 2 diabetes 
Taking medication (s) 
Acute illness 
Regular multivitamin / Vitamin C use 
Recent smoking history 
Lactose intolerance 
Diagnosed with a condition that could 
influence exercise capacity, vascular 
function, or lipid metabolism  
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APPENDIX B 
ELIGIBILITY SCREENING FORM 
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Eligibility Data Form 
(Exercise and Postprandial Endothelial Function in Obese Adolescent Males)  
ED1: Today’s Date: ___/___/___ 
                                   mm  dd    yy 
ED2: Staff Initials: __________ 
 
Complete on own:  
 
ED3: Child’s Name: ______________________________________________________ 
 
ED4: Child’s Age: ________________________________________________________ 
 
ED5: Child’s Date of Birth: ________________________________________________ 
 
ED6: Approximate Weight _____________ Approximate Height____________   
 Calculate BMI ______ 
Calculate BMI percentile__________* 
* An answer below a BMI percentile of 97th makes the person ineligible for the study   
Eligibility Criteria: 
SUBJECTS ARE INELIGIBLE IF ANY ITEM IN A SHADED BOX IS CHECKED  
1. Child is 13-17 years old (ED7) |__| YES |__|  NO 
2. Documented diagnosis of Type 2 Diabetes 
(ED8) 
|__| YES 
 
|__|  NO 
Complete with Parent/Caregiver (ask in person or via phone) 
“If you have a few minutes now I would like to ask for some information to help me determine 
whether you might be eligible to participate in the study.”   
3. Is your child able to perform physical activity without 
any difficulty? (ED9) 
|__| YES 
 
 
|__|  NO 
 
 
4. Does your child participate in exercise/ physical 
activity for more than 60min/day everyday of the 
week?  (ED10) 
|__| YES |__|  NO 
5. Is your child lactose intolerant or have any food 
allergies to dairy products? (ED11) 
|__| YES |__|  NO 
6. Does your child have any medical conditions for 
which he/she receives treatment from a health care 
professional? ** (ED12) 
Specifically: Asthma, Type 1 diabetes 
|__| YES*** 
List:____________
_______ 
________________
________________
___ 
|__|  NO 
7. Is your child taking any medication currently? 
(ED13)*** 
 
|__| YES*** 
List:____________
_______ 
|__|  NO 
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***Medications will have to be examined to 
determine if they will interfere with any of the 
measured outcomes 
________________
________________
________________
________________ 
8. Is your child taking any dietary supplements? 
(ED14) Specifically: Multivitamin, Vit. C supplement, 
or L-arginine containing proteins (e.g. Soy, ect) 
 
**Are they willing to discontinue use for at least 7 
days prior to any visit?  If not, they will need to be 
excluded. 
|__| YES** 
List:____________
_______ 
________________
________________
________________
________________
________________ 
 
 
# If the answer is “Yes”, compare the list of medical conditions to the exclusion criteria below: 
(ED15) 
Orthopedic limitation  
 
|__| YES 
Physical Disability 
  
|__| YES 
Chronic Obstructive Lung Disease  
 
|__| YES 
Emphysema 
 
|__| YES 
Angina 
 
|__| YES 
Prior Myocardial Infarction 
 
|__| YES 
Heart Surgery of any kind 
 
|__| YES 
Other Pulmonary Disease: Specify 
__________________________ 
 
|__| YES 
Cardiovascular Disease: Specify 
____________________________ 
 
|__| YES 
Neurological Disease: Specify 
_____________________________ 
 
|__| YES 
Organic brain syndrome 
 
|__| YES 
Mental retardation 
 
|__| YES 
SUBJECTS ARE INELIGIBLE IF ANY ITEM IN A SHADED BOX IS CHECKED  
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Complete with Parent/Caregiver (ask in person or via phone) 
 
Parent/Caregiver Contact Information 
 
ED16: Name: _____________________________________________________ 
 
ED17: Home Address:_______________________________________________ 
 
City, State, Zip:__________________________________________ 
 
ED18: Phone Number:_____________________________________________ 
 
ED19: Alternative Phone Number: _________________________________ 
 
ED20: Best time to reach you: _______________________________________ 
 
ED21: Email address: _____________________________________________ 
 
ED22: Can you please give me the name, address, and telephone number of a relative or friend 
who would always know how to contact you if we can't reach you? 
 
 Name: 
 ________________________________________________________________ 
 
 Telephone #: ( _ _ _)-( _ _ _)-( _ _ _ _) 
 
 Address: 
 
Are you currently participating in any other ASU-sponsored studies? YES 
 NO 
 
If YES, how much money can you potentially earn by participating in these studies per 
year? 
 
_____________________ 
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STUDY DESIGN AND TIMELINE CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
APPENDIX D 
CHILD ASSENT FORM - ENGLISH 
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CHILD ASSENT for RESEARCH 
 
Study Title: Exercise and Post-Prandial Endothelial Function in Obese 
Adolescent Males 
 
Principal Investigator: Gabriel Q. Shaibi, PhD  
Arizona State University 
Day Time Phone:  602-496-0909 
RESEARCHERS 
Gabriel Shaibi, PhD and Glenn Gaesser, PhD, from Arizona State University 
(ASU) have invited you to be part of a research study. 
STUDY PURPOSE 
The purpose of this study is to see how blood vessels work with exercise and 
diet.  
What we will do 
You will come to the Healthy Lifestyle Research Center (HLRC) at ASU for 4 visits 
described below.  
Baseline Visit (1 hour). 
You will come to ASU in the morning at 9:00 AM before you eat breakfast.  
We will perform the following: 
 A medical and family history. 
 Measure your height, weight, blood pressure, and pulse. 
 We will take a picture of the blood vessels in your arm using an 
ultrasound. 
 We will put a blood pressure cuff on your arm and pump it up for 5 
minutes and then release it and take another picture of your blood vessels 
for 3 minutes. 
 You will perform an exercise test on a stationary bicycle. This test will tell 
us how fit you are. 
 After the exercise test, we will give you a snack and set up your next 
appointment.  
 
Evening Exercise Visit (~1 hour) 
You will come back to ASU at 5:00 PM for an exercise session on a stationary 
bicycle. 
 The exercise session will be based upon the exercise test we did at the 
first visit. We will start with a 5-minute warm-up followed by 8 exercise 
periods that will last for 2 minutes each and will feel like you are pedaling 
a bike up a steep hill. Each hard exercise period will be followed by 2 
minutes of easy pedaling. The total exercise session will last 42 minutes 
and will include a 5-minute cool down. 
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 We will give you a subway gift card and have you pick out a meal to eat 
for that night.  
 
 
Morning Blood Vessel Measurement and Meal Test after Exercise (~5 hours) 
You will come back to ASU at 9:00 AM the next morning after the exercise test. 
You will not be able to eat after 10pm the night before until you come to ASU. 
 We will take a picture of the blood vessels in your arm using an ultrasound. 
 We will put a blood pressure cuff on your arm and pump it up for 5 minutes 
and then release it and take another picture of your blood vessels. 
 We give you a vanilla milkshake for breakfast and ask you to drink it in 10-
minutes.  
 Then we will take 2 more pictures of your arm over the next 4 hours. 
 During this time you will be able to read but not watch TV or use a 
computer 
Blood Vessel Measurement and Meal test without Exercise (~5 hours) 
You will come back to ASU at 9:00 AM during the course of the study. You will not 
be able to eat after 10pm the night before and will have the same subway dinner 
the night before. 
 We will take a picture of the blood vessels in your arm using an ultrasound.  
 We will put a blood pressure cuff on your arm and pump it up for 5 minutes 
and then release it and take another picture of your blood vessels. 
 We give you a milkshake for breakfast and ask you to drink it in 10-
minutes. 
 Then we will take 2 more pictures of your arm over the next 4 hours. 
 During this time you will be able to read but not watch TV or use a 
computer 
 After the last picture, you will walk for about 10min on a treadmill wearing a 
heart rate monitor.  
 
ARE THERE ANY RISKS. 
 You may find parts of this study uncomfortable.  
 The exercise test may make your muscles hurt or feel sore. The exercise 
test may make you sweat, breathe hard, and tired. Some people may get 
dizzy or nauseous (feel like they are going to throw up) when they 
exercise hard. 
 You will perform hard exercise, will be asked to fast overnight, and will be 
asked to consume a large breakfast. 
 You will have to remain seated or lying down for about 4 hours and will not 
be allowed to walk around during this time except to go to the bathroom.  
 We will give you a milkshake that may make your stomach hurt or feel like 
throwing up. 
 
DO I HAVE TO DO THIS 
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You do not have to be in this project. The choice is yours. No one will be mad at 
you if you decide not to do this. Even if you start the project, you can stop later if 
you want. You may ask questions about the study at any time. 
 
WHAT DO I GET FOR DOING THIS 
 You will receive up to $80 for being in this study.  
 You will get information about your fitness level.  
 You will get to feel what it is like to participate in a research project. 
 
 
If you have any questions about the research study, before or after your consent, 
please call Dr. Shaibi, 500 N. 3rd Street, Phoenix, AZ 85004, 602-496-0909.  
 
Your signature below means that you have read this form (or it has been 
read to you) and you want to participate in this study.  
 
Signature of participant_____________________________________________ 
 
 
Participant’s printed name __________________________________________ 
 
 
Date__________________________ 
 
__________________ _______________________ ________________ 
Parent/legal guardian’s Signature      Printed Name.    Date 
 
CONSENT TO BE CONTACTED FOR FUTURE RESEARCH STUDIES. 
 
Dr. Shaibi and his colleagues at ASU have other research projects. You may be 
eligible to participate in. If you would like to be notified of other opportunities for 
research participation please sign below. You can still be in this study even if you 
do not wish to be contacted in the future. 
 
I  DO consent to be re-contacted for future studies. 
 
I  DO NOT consent to be re-contacted for future studies.               
_____________ 
                       
Participant’s initials 
INVESTIGATOR’S STATEMENT. 
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"I certify that I have explained to the above individual the nature and purpose, the 
potential benefits and possible risks associated with participation in this research 
study, have answered any questions that have been raised, and have witnessed 
the above signature. These elements of Informed Consent conform to the 
Assurance given by Arizona State University to the Office for Human Research 
Protections to protect the rights of human subjects. I have offered the participant 
a copy of this signed consent document." 
 
 
 
 
____________________   ________________________      ________________ 
Investigator's Signature /   Printed Name     Date 
Person Obtaining Consent 
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APPENDIX E 
PARENTAL CONSENT FORM – ENGLISH 
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PARENT/LEGAL GUARDIAN INFORMED CONSENT for RESEARCH 
 
Study Title: Exercise and Post-Prandial Endothelial Function in Obese 
Adolescent Males 
 
Principal Investigator: Gabriel Q. Shaibi, PhD  
Arizona State University 
Day Time Phone:  602-496-0909 
INTRODUCTION 
The purpose of this form is: 1) Give you information to help you decide whether 
to let your child participate in this project and 2) Record your agreement for your 
child to be part of this study. 
RESEARCHERS 
Gabriel Shaibi, PhD and Glenn Gaesser, PhD, from Arizona State University 
(ASU) have invited your child to be part of a research study. 
STUDY PURPOSE 
The purpose of this study is to compare the blood vessels of obese youth, and 
see how their blood vessels respond to exercise and diet. We are asking your 
child to take part in this study because he is obese. Up to 30 children will be in 
this study.  
DESCRIPTION OF RESEARCH STUDY 
If you and your child agree to participate, you both will come to the Healthy 
Lifestyle Research Center (HLRC) at ASU for 4 visits described below.  
Baseline Visit (~1 hour). 
You and your child will be scheduled to come to ASU in the morning around 9:00 
AM. Your child will be asked not to eat anything for 10 hours before the visit with 
only having water in the morning. 
We will perform the following: 
 A medical and family history. 
 Measure your child’s height, weight, blood pressure, and pulse. 
 We will take a picture/video of the blood vessels in your child’s arm using 
an ultrasound. This is a similar procedure doctors use on pregnant women. 
For this test your child will have to lie quietly in a bed for about 25 minutes. 
We will take a video of your child’s blood vessel for 1 min then we will inflate 
a blood pressure cuff on their arm for 5 minutes. After we release the blood 
pressure cuff, we will take another picture of your child’s upper arm for 
about 3 more minutes.  
 Your child will perform an exercise test on a stationary bicycle. For this 
test, your child will breathe through a mouthpiece while they pedal on the 
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bike. The exercise test will last about 15 minutes and we will increase the 
resistance during the test until your child will no longer be able to continue. 
We will measure your child's breathing and heart rate before, during, and 
after the exercise test. This test will tell us how fit your child is. 
 After a 10 minute rest period your child will perform an “all-out” bout of 
exercise at the same resistance they ended at on the previous test. Your 
child will push themselves as hard as they feel comfortable with until they 
can no longer continue. This test usually lasts about 2-3 minutes. 
 We will give your child a snack and set up a time for their next visit. 
 
 
Evening Exercise Visit (~1 hour) 
 Your child will be asked to come back to ASU at 5pm for an exercise 
session. The exercise given will be based upon the exercise test we did 
during the baseline visit. 
 The exercise session will be on a stationary bike, after a 5 minute warm-up 
your child will pedal against resistance in 8 stages. Each stage will last 4 
minutes long and they will pedal hard for 2 minutes and easy for 2 minutes. 
They will cool down for 5 minutes afterwards. The total time of the exercise 
session will be about 42 minutes. 
 After the exercise session, your child will be given a subway gift card for 
dinner that night. Your child will get to pick out a specific meal to eat, and 
the meal must be eaten prior to 10pm. 
 Your child will be instructed to not eat any food after 10pm but will be 
allowed to drink water. 
 
 
 
Morning Blood Vessel Measurement and Meal Test following Exercise (~5 hours) 
Your child will be asked to return to ASU at 9:00 AM the morning after the exercise 
visit. We will ask your child not to eat or drink anything after 10 PM the night before 
and not to eat breakfast on this day.  
 We will repeat the ultrasound test described under the baseline visit.  
 We will give your child a vanilla milkshake for breakfast that contains about 
900 calories (60% Fat, 10% Protein 30% Carbohydrate). We will ask them 
to drink the milkshake slowly in under 10 minutes.  
 We will repeat the ultrasound test at 2 hours and 4 hours, after the meal. 
Between measures, we will ask that your child remain seated or lying down 
except to use the restroom. They should bring a book to read or something 
to keep them occupied during this time. We will not allow the use of TV, 
computers, iPad, ect. during this time as they may effect the measures we 
are taking.  
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 After this visit, your child will be given a subway gift card for dinner the night 
prior to the next visit. Your child will eat the same meal as the night prior to 
the other meal visit. 
 
 
Morning Blood Vessel Measurement and Meal Test without Exercise 
Your child will be asked to return to ASU at 9:00 AM. We will ask your child to eat 
the standard selected subway meal the night prior. We will ask your child not to eat 
or drink anything after 10 PM the night before, not to exercise the day before, and 
not to eat breakfast on this day. 
 We will repeat the ultrasound test described previously.  
 We will give your child a vanilla milkshake for breakfast that contains about 
900 calories (60% Fat, 10% Protein 30% Carbohydrate). We will ask them 
to drink the milkshake slowly in under 10 minutes.  
 We will repeat the ultrasound test at 2 hours, and 4 hours, after the meal. 
Between measures, we will ask that your child remain seated or lying down 
except to use the restroom. They should bring a book to read or something 
to keep them occupied during this time. We will not allow the use of TV, 
computers, iPad, ect. during this time as they may effect the measures we 
are taking. 
 At the end of the visit we will ask your child to walk on a treadmill for ~10 
minutes while wearing a heart rate monitor.  
 
 
RISKS. 
There may be parts of this study your child finds uncomfortable. Your child will 
perform vigorous exercise, will be asked to fast overnight, and will be asked to 
consume a high-fat milkshake. Also, your child will have to remain seated or lying 
down for about 4 hours and will not be allowed to walk around during this time 
except to go to the bathroom.  
 
General Discomforts. 
The exercise is likely to make your child sweat, breathe hard, feel tired and make 
their muscles sore. With any hard exercise, they may feel light-headed, out of 
breath, or nauseas. In rare cases people do vomit and / or pass-out after 
exercise testing. Your child will be asked to eat a high fat milkshake and could 
experience diarrhea, vomiting, nausea, stomachache, allergic reaction or food 
poisoning.  
 
COMPENSATION FOR ILLNESS AND INJURY 
 
If you give permission for your child to participate in the study, then your consent 
does not waive any of your legal rights. However, no funds have been set aside 
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to compensate you in the event of injury. However, if any injury occurs due to the 
experimental procedures, first aid will be provided. If there is a situation that the 
researchers believes needs attention by a primary care practitioner, you will be 
referred to the Nurse Practitioner Clinic on the downtown ASU campus. If any 
injury occurs after hours when to the Nurse Practitioner Clinic is closed, you should 
seek attention at an urgent care facility. If a medical emergency were to occur 
during the study, we will call “911” to bring emergency medical personnel to the 
HLRC. You will be responsible for any costs incurred.  
ALTERNATIVE TREATMENTS. 
 
There are no alternative procedures available for this study. 
BENEFITS.  
There may be no direct benefit to you or your child for participating. The 
information from this study will help researchers better understand how exercise 
and diet impact cardiovascular health of youth. Your child will have the 
opportunity to learn about their fitness levels and how scientists use exercise to 
understand how the body works. 
NEW INFORMATION. 
If we find new information during the study that would change your or your child’s 
choice about participating, then we will give you this information. 
CONFIDENTIALITY. 
All information obtained in this study is confidential unless the law makes us 
disclose it. The results of the study may be published or presented but your 
child’s name or identity will be kept private. To keep information private, we will 
use codes to identify research volunteers and only the study team will have 
access to personal information. The study records will be kept locked in Dr. 
Shaibi’s office. 
WITHDRAWAL PRIVILEGE. 
It is ok for you and your child to say no. Even if you say yes now, you both are 
free to say no later, and leave the study at any time. Your choice will not affect 
your relationship with Arizona State University or otherwise cause a loss of 
benefits to which you might otherwise be entitled.  
COST AND COMPENSATION. 
The researchers want your family’s decision about participating in the study to be 
your choice. They understand that participation may cost your family in terms of 
time and travel. Your child will receive compensation for their time and effort and 
free parking will be provided. 
 
Your child will receive up to $80 in compensation ($20 Screening Visit and $30 
for each meal visit). If your child does not finish the tests, they will receive $10 
per hour cash for the time spent, but will not go over the amount stated above for 
each visit. The researchers may ask your child to leave the study at anytime 
without consent. Your child will still be compensated for their time. 
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VOLUNTARY CONSENT. 
Any questions you have concerning the research study or your child’s 
participation, before or after your consent, will be answered by Dr. Shaibi, 500 N. 
3rd Street, Phoenix, AZ 85004, 602-496-0909.  
If you have questions about your child’s rights as a participant in this research, or 
if you feel your family has been placed at risk; you can contact the Chair of the 
Human Subjects Institutional Review Board, through the ASU Office of Research 
Integrity and Assurance, at 480-965 6788.  
This form explains the nature, demands, benefits and any risk of the project. By 
signing this form you agree knowingly to assume any risks involved. Remember, 
your participation is voluntary. You may choose not to participate or to withdraw 
your consent and discontinue participation at any time without penalty or loss of 
benefit except as stated. In signing this consent form, you are not waiving any 
legal claims, rights, or remedies. A copy of this consent form will be given to you.  
Your signature below means that you consent for your child to participate 
in this study.  
 
Your child’s name (please print): ______________________________ 
_________________ ______________________ ________________ 
Parent/legal guardian’s Signature.   Printed Name.     Date 
CONSENT TO BE CONTACTED FOR FUTURE RESEARCH STUDIES. 
 
Dr. Shaibi and his colleagues at ASU have other research projects. Your child 
may be eligible to participate in. If you would like to be notified of other 
opportunities for research participation please sign below. Your child can still be 
in this study even if you do not wish to be contacted in the future. 
I  DO consent to have my child re-contacted for future studies. 
I  DO NOT consent to have my child re-contacted for future studies.         
_____________ 
                      
Parent’s initials 
INVESTIGATOR’S STATEMENT. 
"I certify that I have explained to the above individual the nature and purpose, the 
potential benefits and possible risks associated with participation in this research 
study, have answered any questions that have been raised, and have witnessed 
the above signature. These elements of Informed Consent conform to the 
Assurance given by Arizona State University to the Office for Human Research 
Protections to protect the rights of human subjects. I have offered the participant 
a copy of this signed consent document." 
___________________   ___________________________      _____________ 
Investigator's Signature /   Printed Name     Date 
Person Obtaining Consent 
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CONSENTIMIENTO DEL ADOLESCENTE PARA LA INVESTIGACIÓN 
CIENTÍFICA 
 
Título del estudio: El ejercicio y la función del endotelio después de comer 
en varones adolescentes obesos 
 
Investigador Principal: Gabriel Shaibi, PhD 
Universidad Estatal de Arizona 
Teléfono durante el día: 602-496-0909 
 
INVESTIGADORES 
 
Gabriel Shaibi, PhD y Glenn Gaesser, PhD, de la Universidad Estatal de Arizona 
(ASU) te invitan para que seas parte de un estudio de investigación científica.  
 
PROPÓSITO DEL ESTUDIO 
 
El propósito de este estudio científico es para ver cómo funcionan los vasos 
sanguíneos con el ejercicio y la dieta. 
 
Lo que nosotros haremos 
 
Tu vendrás al Centro de Investigaciones Científicas Estilo de Vida Saludable 
(HLRC) en ASU por 4 visitas relatadas a continuación. 
 
Visita de fundamento (~1 hora). 
 
Tu vendrás a ASU en la mañana a las 9:00 am antes de desayunar. 
 
Juntos vamos a hacer lo siguiente: 
 Un historial medico y familiar. 
 Medir tu estatura, peso, presión arterial y pulso. 
 Vamos a tomar una imagen de los vasos sanguíneos del brazo utilizando 
un ultrasonido. 
 Vamos a poner un manguito de presión arterial en tu brazo y inflarlo para 
mantener la presión en el brazo por 5 minutos, luego liberarla y tomar otra 
imagen de los vasos sanguíneos durante 3 minutos consecutivos. 
 Tu llevarás a cabo una prueba de ejercicio en una bicicleta estacionaria. 
Esta prueba nos dirá tu estado de condición física. 
 Después de la prueba de ejercicio, te daremos una botana y 
estableceremos tu próxima visita. 
 
Visita de Ejercicio por la Tarde  (aproximadamente 1 hora) 
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Tu volverás a ASU a las 5:00 pm de la tarde para una sesión de ejercicio en una 
bicicleta estacionaria. 
 
 La sesión y la intensidad del ejercicio se basara en los resultados 
obtenidos en la prueba de ejercicio que hicimos en la primera visita. 
Vamos a empezar con 5 minutos de calentamiento seguido por un total de 
8 períodos de ejercicio que tendrán una duración de 2 minutos cada uno y 
se sentirá como si estuvieras pedaleando una bicicleta en una montaña. 
Cada periodo de ejercicio severo será seguido por 2 minutos más fáciles 
de pedaleo. El total de la sesión de ejercicio tendrá una duración de 42 
minutos y incluirá un enfriamiento de 5 minutos. 
 Te daremos una tarjeta de regalo para el restaurante Subway y tendrás 
que escoger una comida para comer de cena esa noche. 
 
 
Medidas de los Vasos Sanguíneos por la Mañana y la Prueba de Comida 
Después del Ejercicio (aproximadamente 5 horas) 
 
Tu volverás a ASU a las 9:00 am de la mañana siguiente de la prueba de 
ejercicio. Tu no podrás comer después de las 10:00 pm de la noche anterior, 
tendrás que esperar hasta llegar a ASU. 
 Tomaremos una imagen de los vasos sanguíneos del brazo utilizando un 
ultrasonido. 
 Vamos a poner un manguito de presión arterial en el brazo y 
mantendremos la presión por 5 minutos, luego de liberarla tomaremos 
otra imagen de los vasos sanguíneos. 
 Te daremos un licuado de vainilla para el desayuno, te pediremos que la 
termines de beber en 10 minutos. 
 Después, vamos a tomar 2 más imágenes de tu brazo durante un periodo 
de 4 horas. 
 Durante este tiempo, tu puedes leer o dormir pero no ver la televisión o 
usar la computadora. 
 
Medidas de los Vasos Sanguíneos y la Prueba de Comida Sin Ejercicio (~ 5 
horas) 
 
En el transcurso del estudio tu volverás a ASU a las 9:00 am de la mañana. La 
noche anterior tu no podrás comer después de las 10:00 pm de la noche. 
 Vamos a tomar una imagen de los vasos sanguíneos en el brazo 
utilizando un ultrasonido. 
 Vamos a poner un manguito de presión arterial en tu brazo e inflarla para 
mantener la presión en el brazo por 5 minutos, luego liberarla y tomar otra 
imagen de los vasos sanguíneos. 
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 Te daremos un licuado de vainilla para el desayuno y te pediremos que te 
la termines de tomar en 10 minutos. 
 Después, vamos a tomar 2 más imágenes de tu brazo durante las 
siguientes 4 horas. 
 Durante este tiempo, tu podrás leer o dormir pero no ver la televisión o 
usar la computadora. 
 Después de la última imagen, tu tendrás que caminar durante unos 10 
minutos en la caminadora usando un monitor de frecuencia cardíaca. 
 
EXISTE ALGÚN RIESGO. 
 
 Tu puedes encontrar algunas partes un poco incomodas en este estudio 
científico. 
 La prueba del ejercicio puede hacer que los músculos se sienten 
adoloridos o que duelan. La prueba de ejercicio tal vez te va a hacer 
sudar, respirar con mas fuerza, y a cansarte. Algunas personas cuando 
hacen ejercicio mas duro pueden experimentar mareos o náuseas (sentir 
que tienen que vomitar).  
 Tu vas a hacer ejercicio intenso, también te pediremos que estés en 
ayunas toda una noche, y que consumas un desayuno grande. 
 Tu tendrás que permanecer sentado o acostado por alrededor de 4 horas 
y no podrás caminar durante este tiempo, excepto para ir al baño. 
 Te daremos un licuado que tal vez cause dolor en el estomago o ganas 
de vomitar. 
 
TENGO QUE HACER ESTO 
 
Tu no tienes que ser parte de este proyecto. Tu decides. Si decides no hacerlo 
nadie va a estar enojado con tigo. Incluso si tu decides iniciar el proyecto, si tu lo 
deseas puedes terminar a cualquier momento durante tu participación. Tu 
puedes hacer preguntas sobre el estudio científico en cualquier momento. 
 
QUÉ PUEDO GANAR POR PARCIPAR EN ESTO 
 Tu recibirás hasta $80 dólares por tu participación en este estudio 
científico. 
 Tu recibirás información acerca de tu nivel de condición física. 
 Tu vas a experimentar lo que se siente participar en un proyecto de 
investigaciones científicas. 
 
 
Si tu tienes alguna pregunta sobre el estudio de investigaciones científicas, 
antes o después de tu consentimiento, por favor llama a Dr. Shaibi, 500 N. 3rd 
Street, Phoenix, AZ 85004, 602-496-0909. 
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Tu firma se significa que tu has leído este formulario (o que se te ha leído a 
ti) y deseas participar en este estudio científico.  
 
Firma del Participante _____________________________________________ 
 
Nombre del Participante _________________________________ 
 
Fecha ______________________ 
___________________   _______________________ _______________ 
Firma del tutor legal. Nombre (letra de molde).   Fecha 
 
CONSENTIMIENTO DE CONTACTO PARA FUTUROS ESTUDIOS DE 
INVESTIGACION CIENTIFICA. 
Dr. Shaibi y sus colegas en ASU tienen otros proyectos de investigaciones 
científicas. Tu puedes estar elegible para participar. Si tu quisieras enterarte de 
otras oportunidades para participar en  investigaciones científicas, por favor 
firma abajo. Incluso si tu no deseas ser contactado en el futuro, no te afectaría tu 
participación en este estudio.  
YO  SI doy mi consentimiento para ser contactado nuevamente para estudios 
científicos en el futuro. 
YO  NO doy mi consentimiento para ser contactado nuevamente para 
estudios científicos en el futuro. 
______________________ 
Iniciales de el participante 
DECLARACIÓN DEL INVESTIGADOR. 
"Certifico que he explicado al individuo de arriba la esencia y el propósito, los 
posibles beneficios y los posibles riesgos asociados con la participación en este 
estudio de investigación científica, se han contestado todas las preguntas que se 
han echo, y he sido testigo de la firma de arriba. Estos elementos del Informado 
Consentimiento se ajustan a las garantías dadas por la Universidad Estatal de 
Arizona a la Oficina de Investigación de Protecciones Humanas para proteger 
los derechos de los seres humanos. He ofrecido al participante una copia 
firmada de este documento de consentimiento.” 
 
 
_____________________        ___________________      _________________ 
Firma del Investigador/   Nombre (letra de molde)       Fecha 
Persona obteniento el concentimiento 
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EL CONSENTIMIENTO INFORMADO DE EL TUTOR LEGAL PARA LA 
INVESTIGACIÓN CIENTIFICA 
 
Título del estudio: El ejercicio y la función del endotelio después de comer 
en varones adolescentes obesos 
 
Investigador Principal: Gabriel Shaibi, PhD 
Universidad Estatal de Arizona 
Teléfono durante el día: 602-496-0909 
 
INTRODUCCIÓN 
El propósito de este formulario es: 1) Le dará información que le ayudara a 
decidir si desea permitir que su hijo que participe en este proyecto y 2) Registrar 
que usted esta de acuerdo para que su hijo participe en este estudio científico. 
 
INVESTIGADORES 
Gabriel Shaibi, PhD y Glenn Gaesser, PhD, de la Universidad Estatal de Arizona 
(ASU)  
 han invitado a su hijo para que sea parte de un estudio de investigaciones 
científicas. 
 
PROPÓSITO DEL ESTUDIO 
El propósito de este estudio científico es para comparar los vasos sanguíneos de 
los jóvenes obesos, y ver cómo sus vasos sanguíneos responden al ejercicio y la 
dieta. Porque su hijo es clasificado obeso, estamos pidiendo que el participe en 
este estudio científico. Un máximo de 30 niños serán parte de este estudio 
científico. 
 
DESCRIPCIÓN DEL ESTUDIO DE INVESTIGACIÓN CIENTÍFICA 
Si usted y su hijo están de acuerdo en participar, usted y su hijo vendrán al 
Centro de Investigaciones Científicas Estilo de Vida Saludable (HLRC) en ASU 
por 4 visitas relatadas a continuación. 
 
Visita de fundamento (aproximadamente 1 hora). 
 
Una cita será programada para que usted y su hijo visiten a ASU en la mañana 
alrededor de las 9:00 am. Se le pedirá a su hijo que no coma nada durante 10 
horas antes de la visita, sólo podrá tomar agua por la mañana. 
Vamos a hacer lo siguiente: 
 Un historial médico y familiar. 
 Medir la altura de su hijo, el peso, la presión arterial y el pulso. 
 Vamos a tomar una imagen/video de los vasos sanguíneos en el brazo de 
su hijo por medio de un ultrasonido. Es un procedimiento similar al que los 
médicos utilizan en las mujeres embarazadas. Para esta prueba su hijo 
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tendrá que quedarse acostado en una cama durante unos 25 minutos. 
Vamos a tomar un video de los vasos sanguíneos de su niño durante 1 
min y luego vamos a inflar un manguito de presión arterial en el brazo 
durante 5 minutos. Después de que liberemos el manguito de presión 
arterial, vamos a tomar mas imágenes del brazo de su hijo durante 3 
minutos consecutivos. 
 
 
 Su hijo llevara a cabo una prueba de ejercicio en una bicicleta 
estacionaria. Para esta prueba, su niño respira a través de una boquilla 
mientras pedalea en la bicicleta. La prueba de ejercicio durara unos 15 
minutos, y durante la prueba vamos a aumentar la resistencia hasta que 
su hijo ya no pueda continuar. Vamos a medir la respiración de su hijo y la 
frecuencia cardíaca antes, durante y después de la prueba de ejercicio. 
Esta prueba nos dirá el estado de forma física de su hijo. 
 Después de un período de 10 minutos de descanso su hijo hará ejercicio 
“con toda fuerza” en la misma resistencia que terminó en la prueba 
anterior. Su hijo se motivara a si mismo para  darle duro en la bicicleta 
hasta que ya no pueda continuar. Esta prueba en general dura alrededor 
de 2-3 minutos. 
 Vamos a darle a su hijo una botana y estableceremos el tiempo y fecha 
para la próxima visita.  
 
Visita De Ejercicio Por La Tarde (aproximadamente 1 hora) 
 Su hijo regresara a ASU a las 5 pm de la tarde para una sesión de 
ejercicio. La sesión e intensidad del ejercicio se basara en los resultados 
obtenidos en la prueba de ejercicio que hicimos en la primera visita. 
 La sesión de ejercicio será en una bicicleta estacionaria, después de 5 
minutos de calentamiento su hijo va a pedalear contra la resistencia por 
un total de 8 etapas. Cada etapa tendrá una duración de 4 minutos que 
será pedalear fuerte durante 2 minutos y mas fácil por los otros 2 minutos. 
Después se le dará 5 minutos para enfriamiento. En general el tiempo de 
la sesión de ejercicio será unos 42 minutos. 
 Después de la sesión del ejercicio, su hijo recibirá una tarjeta de regalo 
para el restaurante Subway para que compre su cenar esa noche. Su hijo 
tendrá que elegir una comida específica para que cene, la cena tendrá 
que comerse antes de las 10:00 pm de la noche. 
 Se le indicará a su hijo que no coma ningún alimento después de las 
10:00 de la noche, pero se le permitirá beber agua. 
 
Medidas de los Vasos Sanguíneos por la Mañana y la Prueba de Comida 
Después del Ejercicio (aproximadamente 5 horas) 
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Se le pedirá a su hijo que regrese a ASU a las 9:00 AM de la mañana después 
de la visita del ejercicio. Vamos a pedirle a su hijo que no coma ni beba nada 
después de las 10:00 pm de la noche anterior y esto también incluye no comer 
desayuno el día de esta visita. 
 Vamos a repetir la prueba del ultrasonido que describimos en la parte de 
la primera visita. 
 Vamos a darle a su hijo un licuado de vainilla para el desayuno que 
contiene alrededor de 900 calorías (60% de grasa, 10% de proteínas 30% 
de carbohidratos). Le pediremos que se lo tome lentamente y en menos 
de 10 minutos. 
 Vamos a repetir el ultrasonido después de la comida a las 2 horas y a las 
4 horas. Entre las dos medidas, vamos a pedirle a su hijo que 
permanezca sentado o acostado, con la excepción de ir al baño. El puede 
traer un libro para leer o algo para mantenerse ocupado durante este 
tiempo. Durante este tiempo no vamos a permitir el uso de la televisión, 
computadoras, iPad, etc. ya que puede afectar las medidas que estamos 
tomando. 
 Después de esta visita, su hijo recibirá una tarjeta de regalo para el 
restaurante Subway para         que compre su cena la noche antes de su 
próxima visita. Su hijo va a comer la misma cena que comió la noche 
anterior de la otra visita. 
 
Medidas de los Vasos Sanguíneos y la Prueba de Comida Sin Ejercicio 
 
Se le pedirá a su hijo que vuelva a ASU a las 9:00 AM de la mañana. Vamos a 
pedirle a su hijo que la noche anterior coma la cena que el selecciono del 
restaurante Subway. Vamos a pedirle a su hijo que no coma ni beba nada 
después de la 10:00 de la noche anterior, que no haga ejercicio el día anterior, y 
que no coma desayuno el día de esta visita en ASU. 
 Vamos a repetir el ultrasonido que anteriormente describimos. 
 Vamos a darle a su hijo una malteada de leche de vainilla para el 
desayuno que contiene alrededor de 900 calorías (60% de grasa, 10% de 
proteínas 30% de carbohidratos). Le pediremos que se lo tome 
lentamente y se lo termine en menos de 10 minutos. 
 Vamos a repetir el ultrasonido después de la comida a las 2 horas y a las 
4 horas. Entre las dos medidas, vamos a pedirle a su hijo que 
permanezca sentado o acostado, con la excepción de ir al baño. El puede 
traer un libro para leer o algo para mantenerse ocupado durante este 
tiempo. Durante este tiempo no vamos a permitir el uso de la televisión, 
computadoras, iPad, etc. ya que puede afectar las medidas que estamos 
tomando. 
 Al final de la visita, se le pedirá a su hijo que camine en una caminadora 
durante unos 10 minutos usando un monitor de frecuencia cardíaca. 
RIESGOS. 
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Es posible que haya partes de este estudio que su hijo encuentre incómodas. Su 
hijo realizará un ejercicio vigoroso, se le pedirá que ayune durante la noche y se 
le pedirá que consuma un licuado alta en grasas. Además, su hijo tendrá que 
permanecer sentado o acostado por alrededor de 4 horas y no será permitido 
caminar durante este tiempo, excepto para ir al baño. 
 
MOLESTIAS GENERALES. 
Es probable que con el ejercicio su hijo empiece a sudar, a respirar con mas 
fuerza, a sentirse cansado y con los músculos adoloridos. Como con cualquier 
tipo de ejercicio mas duro, su hijo puede experimentar mareos, fatiga, o 
nauseas. En raras ocasiones algunas personas experimentan  vómito y/o 
desmayos después de la prueba de ejercicio. Se le pedirá a su hijo que se coma 
un licuado alta en grasa y tal vez podría experimentar diarrea, vómitos, náuseas, 
dolor de estómago, reacciones alérgicas o intoxicaciones alimentarias. 
COMPENSACIÓN POR ENFERMEDAD Y LESIONES 
Si usted le da permiso a su hijo para que participe en este estudio científico, su 
consentimiento no cede ninguno de sus derechos legales. Sin embargo, no se 
han reservado fondos financieros para compensar en caso de lesión. Sin 
embargo, si alguna lesión ocurre debido a los procedimientos experimentales, se 
proporcionará primeros auxilios. Si hay una situación en la que los 
investigadores creen que se necesita mas atención de un médico, se le remitirá 
a la Clínica de Enfermeras en el campo de ASU. Si alguna lesión ocurre 
después de que la Clínica de Enfermeras en ASU ya este cerrada, usted debe 
buscar atención en un centro de emergencia medica. Si una emergencia fuera a 
pasar durante el estudio, le llamaremos a "911" para que el personal médico de 
emergencia vengan a el edificio HLRC. Usted será responsable de los gastos 
ocurridos. 
TRATAMIENTOS ALTERNATIVOS. 
No existen otros procedimientos alternativos disponibles para este estudio. 
 
BENEFICIOS. 
Puede que no haya ningún beneficio directo para usted o para su hijo por su 
participación. La información de este estudio científico ayudará a los 
investigadores a entender mejor cómo el ejercicio y la dieta tiene impacto en la 
salud cardiovascular de los jóvenes obesos. Su hijo tendrá la oportunidad de 
aprender acerca de sus niveles de condición física y cómo los científicos usan el 
ejercicio para entender cómo el cuerpo funciona. 
NUEVA INFORMACIÓN. 
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Si nosotros encontramos nueva información durante el estudio que pueda 
cambiar su decisión o la de su hijo acerca de seguir participando, nosotros le 
daremos saber esta información. 
CONFIDENCIALIDAD. 
Toda la información obtenida en este estudio es confidencial al menos que la ley 
nos haga que la revelemos. Los resultados del estudio podrán ser publicados o 
presentados pero el nombre o la identidad de su hijo se mantendrá privada. Para 
mantener la información privada, vamos a utilizar códigos para identificar los 
voluntarios de la investigación y sólo el equipo de estudio tendrá acceso a la 
información personal. Los registros del estudio se mantendrán cerrados con 
llave en la oficina del Dr. Shaibi. 
PRIVILEGIO DE RETIRO. 
Esta bien si usted y su hijo dicen que no. Incluso si usted dice que sí ahora, los 
dos tienen la libertad de decir no durante el estudio y dejar de participar en 
cualquier momento. Su decisión no afectará su relación con la Universidad 
Estatal de Arizona o tampoco causara una pérdida de beneficios a los que de 
otro modo pueda tener derecho. 
COSTO Y COMPENSACIÓN. 
Los investigadores quieren que la opción de participar en el estudio científico 
sea la decisión de su familia. Ellos entienden que su participación puede costarle 
a su familia en términos de tiempo y viajes. Su hijo recibirá una compensación 
por su tiempo y esfuerzo y se le ofrecerá estacionamiento gratuito. 
Su hijo recibirá una compensación de hasta $80 Dólares ($20 en la primera 
visita de selección y $30 por cada visita de comida). Si su hijo no termina los 
exámenes, el recibirá $10 dólares en efectivo por cada hora de su tiempo, pero 
no recibirá mas de la cantidad indicada anteriormente por cada visita. En 
cualquier momento los investigadores pueden pedirle a su hijo que abandone el 
estudio sin previo consentimiento. Su hijo todavía será compensado por su 
tiempo. 
 
CONSENTIMIENTO VOLUNTARIO. 
Cualquier pregunta que tenga sobre el estudio de investigación Científica o de la 
participación de su hijo, antes o después de su consentimiento, serán contestadas por 
Dr. Shaibi, 500 N. 3rd Street, Phoenix, AZ 85004, 602-496-0909. 
Si usted tiene preguntas sobre los derechos que su hijo tiene como participante en esta 
investigación, o si usted siente que su familia ha sido puesta en riesgo, usted puede 
ponerse en contacto con el Presidente de la Junta Institucional de Revisión de Sujetos 
Humanos, a través de la Oficina de Integridad de la Investigación y Aseguramiento de 
ASU, al 480-965 6788. 
Esta forma explica la esencia, las necesidades, los beneficios y los riesgos del proyecto. 
Al firmar este formulario, usted acepta con la capacitación que asumirá cualquier riesgo 
involucrado. Recuerde que su participación es voluntaria. Usted puede optar por no 
participar o de retirar su consentimiento y dejar de participar en cualquier momento sin 
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penalización o pérdida de beneficios, excepto lo que estén indicados aquí. Al firmar este 
formulario de consentimiento, usted no esta cediendo alguna reclamación legal, 
derechos o recursos. Una copia de este formulario se le entregará a usted. 
 
Su firma abajo significa que usted autoriza a que su hijo participe en este estudio 
científico. 
 
 
El nombre de su hijo (letra de molde): ______________________________ 
 
____________________ _________________________ ________________ 
Firma del tutor legal.   Nombre (letra de molde)    Fecha 
 
 
CONSENTIMIENTO PARA SER CONTACTADO/A PARA FUTUROS ESTUDIOS DE 
INVESTIGACIÓN CIENTÍFICA. 
 
Dr. Shaibi y sus colegas en ASU tienen otros proyectos de investigaciones científicas. 
Su hijo puede ser elegible para participar en ellos. Si usted quisiera ser notificado/a de 
otras oportunidades de participación en investigaciones científicas, por favor firme 
abajo. Su hijo todavía puede participar en este estudio, aun si usted no quiere ser 
contactado/a en el futuro. 
 
YO  SI, doy mi consentimiento para que mi hijo sea contactado para futuros estudios. 
 
YO  NO, doy mi consiento para que mi hijo vuelva a ser contactado para futuros 
estudios.          
__________________ 
                       
Iniciales del tutor legal 
DECLARACIÓN DEL INVESTIGADOR. 
"Certifico que he explicado al individuo de arriba la esencia y el propósito, los posibles 
beneficios y los posibles riesgos asociados con la participación en este estudio de 
investigación científica, se han contestado todas las preguntas que se han echo, y he 
sido testigo de la firma de arriba. Estos elementos del Informado Consentimiento se 
ajustan a las garantías dadas por la Universidad Estatal de Arizona a la Oficina de 
Investigación de Protecciones Humanas para proteger los derechos de los seres 
humanos. He ofrecido al participante una copia firmada de este documento de 
consentimiento.” 
 
 
____________________          _______________________                      ________ 
Firma del Investigador/     Nombre (letra de molde)        Fecha 
Persona obteniento el concentimiento 
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APPENDIX H 
FLYER-ENGLISH 
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We are looking for adolescent males for a research project about 
diet, exercise and health. 
Adolescents Qualify If: 
 They are between 13-17 years old 
 Are overweight but otherwise healthy 
 
What’s involved? 
 Coming to ASU on 4 different occasions 
 Measuring height and weight  
 Exercising on a stationary bike 
 Drinking a milkshake for breakfast 
 Ultrasound measures of their arm 
Compensation!!! 
 If you complete the 4 visits you will get paid $80 in cash 
 We will also provide 2 breakfasts and 2 dinners 
 
For more information please contact: 
Jrryder@asu.edu 
(602) 910-4997 
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APPENDIX I 
FLYER-SPANISH 
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Estamos buscando a varones adolescentes para que 
participen en un proyecto de investigaciones científicas 
acerca de la dieta, el ejercicio y la salud 
 
Los adolescentes califican si: 
 
 Tienen entre 13 a 17 años de edad 
 Están sobrepeso pero a la misa vez sanos 
 
¿Qué se implica? 
 
 Venir a ASU en 4 diferentes ocasiones 
 Tomar medidas de la altura y el peso 
 Hacer ejercicio en una bicicleta estacionaria 
 Beber un licuado para el desayuno 
 Tomar medidas de su brazo con un ultrasonido 
 
Compensación 
 Los participantes que terminen las 4 visitas recibirán $80 
dólares en efectivo 
 También les proveeremos 2 desayunos y 2 cenas 
 
Para más información, por favor comunicarse con 
Estela Barraza 
por correo electrónico a estela.barraza@asu.edu  
o por teléfono al (602) 888-3046 
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APPENDIX J 
DATA COLLECTION SHEETS 
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Visit 1: Screening                   Date: 
 
Consent    |_____________|______________|___________________|  Notes:  
             Complete              Initial     Time 
 
Assent    |_____________|______________|___________________|  Notes:  
             Complete              Initial     Time 
 
Anthropometrics    |_____________|______________|___________________|  Notes:  
                  Complete              Initial          Time 
 
Blood Pressure    |_____________|______________|___________________|  Notes:  
          Complete              Initial      Time 
 
FMD    |_____________|______________|___________________|___________|  
Notes:  
        Complete              Initial              Time                   Eligible? 
 
VO2peak    |_____________|______________|___________________|  Notes:  
              Complete               Initial        Time 
 
Verification Phase    |_____________|______________|___________________|  Notes:  
                       Complete              Initial             Time 
 
 
Exercise Visit               Date:  
              
 
Completion of visit    |_____________|______________|___________________|  
Notes:  
                      Complete               Initial            Time 
 
 
Number of bouts completed = _________________ (tally)_____# 
 
 
Number of bouts completed within HR range 
=_________________________(tally)_______# 
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Meal Visit Post Exercise             Date: 
 
Blood Pressure    |_____________|______________|___________________|  Notes:  
          Complete              Initial      Time 
 
Baseline FMD    |_____________|______________|___________________|  Notes:  
                       Complete              Initial    Time                    
 
Meal Ingestion    
|_____________|______________|___________________|_____________| Notes:  
                        Complete              Initial    Time                      
Tolerated? 
 
2 Hour FMD    |_____________|______________|___________________|  Notes:  
                       Complete              Initial    Time                    
 
4 Hour FMD    |_____________|______________|___________________|  Notes:  
                       Complete              Initial    Time                    
 
Meal Visit NO  Exercise             Date: 
 
Blood Pressure    |_____________|______________|___________________|  Notes:  
          Complete              Initial      Time 
 
Baseline FMD    |_____________|______________|___________________|  Notes:  
                       Complete              Initial    Time                    
 
Meal Ingestion    
|_____________|______________|___________________|_____________| Notes:  
                        Complete              Initial    Time                      
Tolerated? 
 
2 Hour FMD    |_____________|______________|___________________|  Notes:  
                       Complete              Initial    Time                    
 
4 Hour FMD    |_____________|______________|___________________|  Notes:  
                       Complete              Initial    Time                    
 
 
129 
 
SUBEJCTS #:_____________   DOB:______/__________/________  
AGE:________(yr) 
WEIGHT:____________ (lb)_____________(kg)  
HEIGHT:_______________(in)__________(cm) 
BMI (kg/m
2
):________________ 
 BMI(percentile):______________________________ 
________________________________________________________________________ 
    TRIAL 1     TRIAL 2        TRIAL 3             
MEAN HR 
Morning BP (Screening):    _____/_____     ______/___       ______/_____   
______/______   ______                  
Morning BP (M+Ex):          _____/_____     ______/___       ______/_____   
______/______    ______                      
Morning BP (M only):         _____/_____     ______/___       ______/_____   
______/______    _______                                            
________________________________________________________________________ 
Meal Dose 
G fat needed:_____________   Meal break down: _________(g 
HWC)____________(g Ice Cream) 
Exercise day (V1): Time of arrival:___________________    Confirm fasted:  Yes /  
No 
McMaster Protocol    
RATE:   50-60rpm   Initial load (Watts):__________  
VO2peak begin time:_____________________ VO2peak end 
time:______________________ 
Rest time: Start___________End____________Total amount of rest: 
_____________________ 
Verification phase:  Work load:_____________________ 
Start time:______________End:_____________  Total time:____________________ 
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VO2peak (ml/kg/min):____________________ HRmax(bpm):________________  
Workmax_________ 
50% HRmax:_________________ Power (Watts):___________________ 
90%HRmax:_________________  Power (Watts):___________________ 
Notes: 
 
Exercise + Meal Day (V2): Time of arrival:____________________   Confirm 
fasting: Y / N 
Approximate time of last meal consumption:___________________ 
Baseline FMD (Pre-meal): Time:________________ 
Meal consumption----Time: Start___________End_______________Total eat 
time:______________ 
2 hour post-meal consumption FMD: Time:___________________ 
4 hour post-meal consumption FMD: Time:___________________ 
Notes: 
 
________________________________________________________________________
Meal Only Day (V3): Time of arrival:____________________  Confirm fasting: Y / 
N 
Approximate time of last meal consumption:___________________ 
Baseline FMD (Pre-meal): Time:________________ 
Meal consumption----Time: Start___________End_______________Total eat 
time:______________ 
2 hour post-meal consumption FMD: Time:___________________ 
4 hour post-meal consumption FMD: Time:___________________ 
Notes: 
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Submaximal VO2 test:  
Weight: ______________ (kg)   Height: _______________ (cm) Resting HR: 
_________________(bpm) 
Start Time:_______________  End Time:__________________ 
Measured during test: 
4 min HR: _______________ (bpm)  
HR Difference: _______________ (bpm)  
Speed: ______________(mph) 
 
Estimated VO2max:_____________________ 
VO2= -1772.81 + 318.64 * sex (F=0, M=1) + 18.34 * weight (kg) + 24.45 * Height 
(cm) – 8.74 * 4minHR – 0.15 * Weight (kg) * HR Difference + 4.41 * Speed (mph) * 
HR Difference. 
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APPENDIX K 
LABORATORY FLOW-MEDIATED DILATION ASSESSMENT PROTOCOL 
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I. Subject Preparation 
a. Controls: 
i. Time of day: diurnal variation can effect FMD so Pre-Post 
measurements should be taken at the same time of day 
ii. Caffeine: no caffeine intake for 24 hours 
iii. Alcohol: no alcohol intake for 48 hours 
iv. Smoking: Refrain from smoking for > 12 hours if smokers are 
allowed in study 
v. Vitamins or supplements: no vitamins or supplements for 72 hours 
vi. Medications: all medications should be avoided for > 4 half-lives 
of the drug. Especially beta blockers, nitrates, and calcium channel 
blockers. Also NSAIDS should be avoided for 1 day and aspirin 
for 3 days. 
vii. Menstrual cycle: FMD should occur during days 1-7 of the 
menstrual cycle (ie: early follicular phase). Day 1 is when menses 
begins. 
viii. Prior exercise: subjects should avoid vigorous exercise for 24 
hours also subjects should be instructed to reduce physical activity 
to as little as possible 24 hours prior. 
ix. Fasting measurements: should be taken at least 6 hours fasted 
x. Non-dominant arm: For cross-sectional studies the non-dominant 
arm should be used for FMD measurement 
b. Procedures: 
i. Lay down in a quiet dimly lit room, with no distractions, and 
temperature controlled for at least 20 minutes 
1. No cell phone use or music during this time 
2. Lay on back with legs fully extended 
3. Subjects should refrain from watching TV or engaging in 
any activity which might cause emotion before the FMD 
ii. Make sure subject is comfortable with arm and head fully 
supported 
1. Towel or foam rolls should be placed proximal to the elbow 
and at the mid forearm just distal to the cuff placement 
a. The towels/foam should hold the arm off of the 
table so that the cuff is not resting on the table while 
inflated 
2. The shoulder should be slightly externally rotated and at 80 
degrees of abduction 
3. If the subject cannot keep his/her arm externally rotated the 
opposite side of the table can be lifted to support the body 
to allow the subject to lay on their side 
 
II. Device Preparation 
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a. Ultrasound gel should be used and preferable warmed with a gel warmer 
to increase subject comfort 
b. The blood pressure cuff (of appropriate size) should be placed just distal to 
the elbow (~1cm) and tightened snugly around the forearm 
i. If the subject has a very small arm (ie child or very small adult) 
then a child size cuff should be used  
c. Table height should be adjusted so the sonographer can maintain a neutral 
angle at the wrist while imaging 
d. The sonography chair should be used so that the arms are utilized as arm 
rests 
e. The ultrasound probe should be held so that the notch on the top portion 
faces medially 
i. Reversal of this will make arteries blue and veins red in color 
mode 
 
III. Image Preparation and Terason Settings  
a. Color Mode: 
i. Find artery  
1. Red colored pulsating blood flow 
2. May need to move yellow box to encompass artery 
3. Slow, subtle movements are needed in order to find artery 
the best 
ii. Adjust depth to find optimal image quality 
1. Larger subjects will require deeper imaging (ie: 4-6 cm), 
very lean subjects will require shallow imaging (ie: 2-3 cm) 
iii. Adjust focal zone to find optimal view of the artery 
iv. Find a section of the artery that is clear across the whole screen if 
possible 
1. Slide proximal and distal until desired artery section is 
found 
2. Once optimal location is found measure the distance from 
the medial epicondyle to the distal end of the probe and 
record this distance 
3. Also draw a small line at the distal end of the probe, so you 
have a reference point to come back to as well as seeing if 
you are moving the probe during recording 
b. 2-D Mode:  
i. Adjust frequency to find optimal setting (typical optimal setting is 
“High”, but sometimes “Medium” results in a better image) 
ii. Increase rejection to decrease the amount of noise in the arterial 
lumen 
iii. Decrease compression to make the artery walls brighten 
iv. Adjust time gain compensation (TGC) sliders to brighten artery 
walls and decrease noise in lumen 
135 
 
1. These are positional adjustments that align with the portion 
of the image that is just left of the slider on the screen 
v. Turn the “zoom” on then select a region about 0.5 - 1 cm above 
and below the artery encompassing the entire length of the artery if 
possible (if the entire screen length is not clear then only select the 
section that is clear) 
vi. Readjust compression, rejection, and TGC sliders now that the 
image is zoomed (it is normal to have to increase rejection more 
and decrease the TGC sliders that are aligned with the lumen after 
zooming) 
vii. Once the image is clear with crisp upper and lower artery walls and 
a noiseless lumen you can move on to Pulse Wave Mode 
c. Pulse Wave Mode: 
i. Place SV cursor in the artery lumen all the way on one side or the 
other (do not place the cursor in the center of the artery, the 
software will mistake the cursor for artery walls) 
ii. Decrease the “sound volume”, the default is very loud 
iii. Increase SV size to encompass the entire artery lumen without 
touching the walls 
iv. Decrease the Baseline so that there is only a small portion of the 
negative blood flow velocity region visible (you will need as much 
visible in the positive direction for immediately after cuff release) 
v. Adjust the Gain knob in a clockwise direction to increase the 
sensitivity of the SV cursor or in a counterclockwise direction to 
decrease.  
1. Decrease gain when extra noise is being picked up outside 
of the typical pulse waves; Increase gain when the waves 
are dim and quiet 
2. This can be adjusted continuously while recording 
 
IV. Flow-Mediated Dilation and Image Recording 
a. Baseline image 
i. Once both the image and the blood velocity signal are clear you are 
ready to record the baseline image 
ii. With the cuff not inflated record a 1 minute video at rest 
iii. Click “stop” then save the video file 
iv. Alternatively you can continue the recording and record all the 
way through cuff inflation up until 3 to 5 minutes post cuff release. 
b. Occlusion 
i. After recording the baseline image inflate the cuff to ~250 mmHg 
(supra-systolic is all that is necessary, but at least 200 is suggested) 
ii. Start a stop watch as soon as the target pressure is reached 
iii. Start imaging again soon after inflation 
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1. Some arteries can move substantially during occlusion so it 
may take a while to obtain a good image again 
2. If substantial artery movement occurs then reset the TGC 
sliders (since these are positional) 
3. Go through all 3 modes again and make sure you have a 
clear image and velocity signal 
iv. Start recording again at 4 minutes of occlusion, this will allow you 
to obtain 1 minute of post-occlusion baseline image before cuff 
deflation 
c. FMD 
i. After you start recording the post-occlusion baseline video click 
the SV cursor to obtain control so that you can move the cursor in 
case the artery moves with cuff deflation 
ii. Have an assistant release the cuff at exactly 5 minutes of occlusion 
(longer or shorter occlusion times will result in different outcomes) 
iii. Record the video for at least 3 minutes after cuff deflation 
1. For patients with cardiovascular disease and elderly 
patients 5 minutes of post-deflation video is necessary 
iv. After the recording time is complete click “stop” and save the 
video file 
 
V. Analysis using the lab view based Dicom encoder software by Ryan Harris 
a. Blinding, randomizing, and assessing reliability 
i. Before analysis begins a non-biased investigator should change all 
of the file names in order to blind the investigator who is 
conducting the analysis 
ii. The subject ID, condition, and/or time of the file should not be 
known to the investigator conducting the analysis 
iii. For each study it is recommended that a random sample of 10 
images should be analyzed twice in order to assess intra-rater 
reliability 
1. Reliability should be assessed with coefficients of variation 
and Intra-class correlation coefficients 
b. Settings tab 
i. Select the folder you want to access the AVI files from in the AVI 
tab 
ii. Select the folder you want to save the analysis file to or access an 
analysis file from using the analysis tab 
iii. Select correct analysis options: ultrasound machine type, analysis 
type, etc 
iv. Input changes on patient files 
c. Acquire tab 
i. Choose avi file  input start and stop times  input patient name, 
DOB, and ID number 
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ii. Choose csv file and name the file (already should be selected)  
click return 
iii. Click on “show graph” (this is best on a dual monitor system, then 
you can have one monitor with the graph and the other with the 
acquire tab) 
iv. Review entire video to identify good ROI 
v. Click on the X for Diameter ROI  select ROI  click save ROI 
1. Rules on ROI selection:  
a. Select the largest ROI possible while still 
maintaining stable walls 
b. The upper and lower lines can be adjusted while 
analysis is going, but the length of the ROI box 
(right and left lines) should not be changed 
2. Scroll through video to see if you need to change ROI for 
different sections of the video 
3. Click “calibrate” next to ROI 
a. Each large tick mark is 1.0 cm 
b. Use automatic if the lines snap to the large tick 
marks correctly, if not then manually place the lines 
in the correct location 
vi. Click the X next to velocity ROI 
1. Select the entire velocity graph (inside of upper and lower 
tick marks and outside of right and left tick marks) 
2. Click Save ROI and the right and left lines should snap to 
the graph borders and you should see yellow dots tracing 
the waves 
3. Next click calibrate next to velocity 
a. Select an appropriate range on the y-axis, choose 
the value range that you are selecting (or type in a 
user defined range) then click calibrate 
b. Make sure the lines snap to the range you chose 
c. This can be done manually too if auto is not 
working 
vii. Click “analyze”  watch the entire video and graphing carefully 
to make sure the diameter ROI is optimal. You can change the 
upper and lower walls as necessary throughout the analysis process 
viii. Once it finishes it should ask you to save file; if it doesn’t then 
click analyze again then immediately click exit, it will then ask you 
if you want to save 
d. Analysis tab 
i. Select file 
ii. Select the appropriate cursor control: 
1. FMD only: when you have baseline and FMD in the same 
video 
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2. Beginning/end only: when you have only a baseline image 
at rest 
iii. For beginning/end only put one blue line on one end of the image 
and leave the other at the beginning  
iv. For FMD only: 
1. The first red line is baseline begin, put this just after the 
start of baseline 
2. The second red line is baseline end, put this just before cuff 
release 
3. The first green line is FMD begin, put this just right at cuff 
release 
4. The second green line is FMD end, put this after the peak 
dilation 
5. The next line is the dashed blue line which should go at the 
end of the video 
v. Manual outlier removal: 
1. By placing the two dashed blue lines around a section and 
pressing the space bar you can remove sections of the data 
2. This should be done for spikes in the data that are 
obviously errant data 
a. If the spike is greater than 0.01 cm above the rest of 
the data around that point then it should be 
manually removed 
b. This should be done before the automatic outlier 
removal 
vi. Next, click data control and select remove outliers (do this once 
only) 
vii. Above calculate choose the analysis type 
1. Polyfit is the most conservative and our preferred method 
viii. Click calculate 
ix. Make sure the software chose the appropriate peak diameter 
location if there is an obvious peak 
x. Scroll through the output on the bottom to obtain baseline 
diameter, peak diameter, FMD %, blood flow values, and shear 
rate values 
xi. Click “copy” then past the results into an excel sheet 
xii. Make sure you use the pre-cuff inflation baseline to calculate 
FMD.  
1. You can do this manually if your baseline and FMD files 
are separate 
2. Or if you continued recording all the way through you can 
have the software calculate this for you. 
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APPENDIX L 
PRELIMINARY DATA 
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Preliminary data from pilot study on lean youth aged 11-16 years old (n=8). Data are 
presented as mean ± SE. Consumption of a high-fat breakfast was associated with a 28% 
decrease in FMD at 4hr when high-intensity exercise was “prescribed” 16hrs prior to 
consuming the high-fat breakfast, we observed an improvement of a 16% increase in 
FMD at 4hr. The exercise appeared to blunt or mitigate any postprandial endothelial 
dysfunction which was observed.  
 
 
 
 
 
 
 
 
141 
 
APPENDIX M 
MILKSHAKE BREAKDOWN BY BODY WEIGHT 
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Appendix N 
STANDARD MEAL DESCRIPTION 
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Participants were allowed to choose from any of the following meals to consume on 2 
evenings prior to morning meal visits. These meals were consumed prior to 22:00 and 
were asked to be consumed with water. Instruction on to maintain the same bread type, 
cheese, and toppings were given. Participants were asked to refrain from chips or soda. 
Participants were asked to consume the entire foot-long subway sandwich. The nutrition 
data for each sandwich allowed is provided below. Note: these are for 6 inch sandwich’s 
with no toppings.  
  
 
                
Black 
Forest 
Ham 
216  290  40  4.5  1.0  0.0  20  800  46  5  8  18  8  20  30  15  
Roasted 
Chicken  
230  320  40  5.0  1.5  0.0  40  610  47  5  8  23  8  30  30  15  
Roast 
Beef 
230  320  40  5.0  1.5  0.0  40  660  45  5  7  24  8  20  30  25  
Subway 
Club®  
237  310  40  4.5  1.5  0.0  40  800  46  5  7  23  8  20  30  20  
Sweet 
Onion 
Chicken 
Teriyak
i 
265  370  40  4.5  1.0  0.0  50  770  57  5  16  25  10  25  35  20  
Turkey 
Breast 
216  280  30  3.5  1.0  0.0  20  670  46  5  7  18  8  20  30  15  
 Turkey 
Breast 
& Ham  
216  280  35  4.0  1.0  0.0  20  730  46  5  8  18  8  20  30  1 
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Appendix O 
FMD ANALYSIS PROCEDURES AND RELIABILITY 
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FMD analysis procedures and reliabilty 
•All FMD files were blinded and randomized from the sonographer prior to analysis
•All files were analyzed in duplicate, blinded with CV% and ICC calculated
•If files CV% was >50%, the files was analyzed a third time
•This was conducted on 5 files (of 168) with 4/5 showing close agreement with one file 
•The one file which could not show agreement was excluded from analysis (2hr Ex+M)
•The mean value for each files baseline diameter and peak diameter was used 
•10 peak and 10 baseline images were randomized and blinded
•Images were analyzed by 3 different observes
•Images were un-blinded and CV% and ICC with original sonographer were calculated
•Intra-user reliability (n=168)
•Baseline diameter:  CV% = 0.51% ; ICC = 0.998
•Peak diameter:  CV% = 0.64%; ICC = 0.997
•FMD%: CV% = 11.31%; ICC = 0.965
•Inter-rater reliability (n=20, range with 3 observers)
•Baseline diameter:  CV% = 0.65-0.73%; ICC = 0.993-0.995
•Peak diameter:  CV% = 0.59-0.82; ICC = 0.993-0.996
•FMD%: CV% = 5.8-7.7%; ICC = 0.931-0.989
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Appendix P 
RECRUITMENT AND PARTICIPANT ENROLLMENT 
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Recruitment and eligibility of participants
Ineligible (n=7)
Screened (n=22) Liver Disease (n=1)
Flyer (n=2) Medication (n=1)
Social Media (n=5) BMI <97
th
 %tile (n=5)
Schools (n=1)
Existing Studies (n=4)
Community Organizations (n=3) Eligible (n=15)
Newspaper ad (n=7) Enrolled (n=14)
Completed (n=14)
Compliance = 100%
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Appendix Q 
BLAND-ALTMAN PLOT OF FASTING FMD VALUES 
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Appendix Q is a Bland-Altman plot of fasting FMD values, with the difference between 
values being screening FMD – fasting FMD during the meal only visit.  There is a 
difference between fasting values of 0.48±2.5%.  The values were modestly associated 
with each other, r = 0.554, P=0.040. These values had an inter-class correlation 
coefficient of  0.712, suggesting modest reliability. The R
2
 of this relationship is 0.307, or 
30.7% of the variance in fasting FMD during the meal is explained by screening FMD, 
leaving 69.3% of the variance due to other factors.  
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